Lincoln National Corp: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Oct 30, 2025 and accepted by EDGAR at Oct 30, 2025, 13:32 ET.
Management's discussion and analysis
As filed, 178,557 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
| Page | |
|---|---|
| Forward-Looking Statements – Cautionary Language | 83 |
| Introduction | 84 |
| Executive Summary | 84 |
| Summary of Critical Accounting Estimates | 86 |
| Results of Consolidated Operations | 93 |
| Results of Annuities | 95 |
| Results of Life Insurance | 100 |
| Results of Group Protection | 106 |
| Results of Retirement Plan Services | 110 |
| Results of Other Operations | 115 |
| Consolidated Investments | 117 |
| Liquidity and Capital Resources | 133 |
82
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the financial condition as of September 30, 2025, compared with December 31, 2024, and the results of operations for the three and nine months ended September 30, 2025, compared with the corresponding periods in 2024 of Lincoln National Corporation and its consolidated subsidiaries. Unless otherwise stated or the context otherwise requires, “LNC,” “Company,” “we,” “our” or “us” refers to Lincoln National Corporation and its consolidated subsidiaries.
The MD&A is provided as a supplement to, and should be read in conjunction with, the consolidated financial statements and the accompanying notes to the consolidated financial statements (“Notes”) presented in “Part I – Item 1. Financial Statements” and our Annual Report on Form 10-K for the year ended December 31, 2024 (“2024 Form 10-K”). For more detailed information on the risks and uncertainties associated with the Company’s business activities, see the risks described in “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K.
FORWARD-LOOKING STATEMENTS – CAUTIONARY LANGUAGE
Certain statements made in this report and in other written or oral statements made by us or on our behalf are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements. Forward-looking statements may contain words like: “anticipate,” “believe,” “estimate,” “expect,” “project,” “shall,” “will” and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, trends in our businesses, prospective services or products, future performance or financial results and the outcome of contingencies, such as legal proceedings. We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.
Forward-looking statements are subject to risks and uncertainties. Actual results could differ materially from those expressed in or implied by such forward-looking statements due to a variety of factors, including:
- Weak general economic and business conditions that may affect demand for our products, account balances, investment results, guaranteed benefit liabilities, premium levels and claims experience;
- Adverse global capital and credit market conditions that may affect our ability to raise capital, if necessary, and may cause us to realize impairments on investments and certain intangible assets, including goodwill and the valuation allowance against deferred tax assets, which may reduce future earnings and/or affect our financial condition and ability to raise additional capital or refinance existing debt as it matures;
- The inability of our subsidiaries to pay dividends to the holding company in sufficient amounts, which could harm the holding company’s ability to meet its obligations;
- Legislative, regulatory or tax changes, both domestic and foreign, that affect: the cost of, or demand for, our subsidiaries’ products; the required amount of reserves and/or surplus; our ability to conduct business; our affiliate reinsurance arrangements; and restrictions on the payment of revenue sharing and 12b-1 distribution fees;
- Changes in tax law or the interpretation of or application of existing tax laws that could impact our tax costs and the products that we sell;
- The impact of regulations adopted by the Securities and Exchange Commission (“SEC”), the Department of Labor or other federal or state regulators or self-regulatory organizations that could adversely affect our distribution model and sales of our products and result in additional disclosure and other requirements related to the sale and delivery of our products;
- The impact of new and emerging rules, laws and regulations relating to privacy, cybersecurity and artificial intelligence that may lead to increased compliance costs, reputation risk and/or changes in business practices;
- Increasing scrutiny and evolving expectations and regulations regarding environmental, social and governance matters that may adversely affect our reputation and our investment portfolio;
- Actions taken by reinsurers to raise rates on in-force business;
- Declines in or sustained low interest rates causing a reduction in investment income, the interest margins of our businesses and demand for our products;
- Rapidly increasing or sustained high interest rates that may negatively affect our profitability, value of our investment portfolio and capital position and may cause policyholders to surrender annuity and life insurance policies, thereby causing realized investment losses;
- The impact of the implementation of the provisions of the European Market Infrastructure Regulation relating to the regulation of derivatives transactions;
- The initiation of legal or regulatory proceedings against us, and the outcome of any legal or regulatory proceedings, such as: adverse actions related to present or past business practices common in businesses in which we compete; adverse decisions in significant actions including, but not limited to, actions brought by federal and state authorities and class action cases; new decisions that result in changes in law; and unexpected trial court rulings;
- A decline or continued volatility in the equity markets causing a reduction in the sales of our subsidiaries’ products; a reduction of asset-based fees that our subsidiaries charge on various investment and insurance products; and an increase in liabilities related to guaranteed benefit riders, which are accounted for as market risk benefits (“MRBs”), of our subsidiaries’ variable annuity products;
- Ineffectiveness of our risk management policies and procedures, including our various hedging strategies;
- A deviation in actual experience regarding future policyholder behavior, mortality, morbidity, interest rates or equity market returns from the assumptions used in pricing our subsidiaries’ products and in establishing related insurance reserves, which may reduce future earnings;
- Changes in accounting principles that may affect our consolidated financial statements;
- Lowering of one or more of our debt ratings issued by nationally recognized statistical rating organizations and the adverse effect such action may have on our ability to raise capital and on our liquidity and financial condition;
- Lowering of one or more of the insurer financial strength ratings of our insurance subsidiaries and the adverse effect such action may have on the premium writings, policy retention, and profitability of our insurance subsidiaries and liquidity;
- Significant credit, accounting, fraud, corporate governance or other issues that may adversely affect the value of certain financial assets, as well as counterparties to which we are exposed to credit risk, requiring that we realize losses on financial assets;
- Interruption in or failure of the telecommunication, information technology or other operational systems of the Company or the third parties on whom we rely or failure to safeguard the confidentiality or privacy of sensitive data on such systems, including from cyberattacks or other breaches in security of such systems;
- The effect of acquisitions and divestitures, including the inability to realize the anticipated benefits of acquisitions and dispositions of businesses and potential operating difficulties and unforeseen liabilities relating thereto, as well as the effect of restructurings, product withdrawals and other unusual items;
- The inability to realize or sustain the benefits we expect from, greater than expected investments in, and the potential impact of efforts related to, our strategic initiatives;
- The adequacy and collectability of reinsurance that we have obtained;
- Pandemics, acts of terrorism, war or other man-made and natural catastrophes that may adversely impact liabilities for policyholder claims and adversely affect our businesses and the cost and availability of reinsurance;
- Competitive conditions, including pricing pressures, new product offerings and the emergence of new competitors, that may affect the level of premiums and fees that our subsidiaries can charge for their products;
- The unknown effect on our subsidiaries’ businesses resulting from evolving market preferences and the changing demographics of our client base; and
- The unanticipated loss of key management or wholesalers.
The risks and uncertainties included here are not exhaustive. Other sections of this report and other reports that we file with the SEC include additional factors that could affect our businesses and financial performance, including “Part I – Item 1A. Risk Factors” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.
Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to correct or update any forward-looking statements to reflect events or circumstances that occur after the date of this report.
INTRODUCTION
Executive Summary
We are a holding company that operates multiple insurance and retirement businesses through subsidiary companies. We sell a wide range of wealth accumulation, wealth protection, group protection and retirement products and solutions through our four business segments:
- Annuities
- Life Insurance
- Group Protection
- Retirement Plan Services
We also have Other Operations, which includes the financial results for operations that are not directly related to the business segments. See “Part I – Item 1. Business” in our 2024 Form 10-K for a discussion of our business segments and products.
In this report, in addition to providing consolidated net income (loss), we also provide income (loss) from operations because we believe it is a meaningful measure of the profitability of our business segments and Other Operations. Income (loss) from operations is the financial performance measure we use to evaluate and assess the results of our segments and Other Operations. Accordingly, we define and report income (loss) from operations by segment in Note 16. Our management believes that income (loss) from operations explains the results of our ongoing businesses in a manner that allows for a better understanding of the underlying trends in and performance of our current businesses. Certain items are excluded from income (loss) from operations because they are not necessarily indicative of current operating fundamentals or future performance of the business segments, and, in most instances, decisions regarding these items do not necessarily relate to the operations of the individual segments.
We provide information about our business segments’ and Other Operations’ operating revenue and expense line items, key drivers of changes and historical details underlying the line items below. For factors that could cause actual results to differ materially from those set forth, see “Forward-Looking Statements – Cautionary Language” above and “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K.
On June 5, 2025, we closed our previously announced stock sale transaction pursuant to the purchase agreement (the “Purchase Agreement”) with Bain Capital Prairie, LLC (the “Buyer”), a newly formed subsidiary of Bain Capital, under which we agreed to sell shares representing 9.9% of our outstanding common stock on a post-issuance basis to the Buyer. Under the final terms, Lincoln sold approximately 18.8 million shares of its common stock for aggregate consideration of $825 million. The transaction provided us with capital that we expect to deploy toward our strategic priorities, including growing spread-based earnings, advancing our portfolio management efforts and asset sourcing capabilities and optimizing our legacy life portfolio. For additional information on the Bain Capital transaction, see Note 15.
Industry trends and significant operational matters are described in “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” of our 2024 Form 10-K, which is further updated by the discussion that follows.
Interest Rate Environment
During the third quarter of 2025, the Federal Reserve announced a 25 basis point reduction in the federal funds rate target range to 4.00% to 4.25%, as the labor market shows signs of softening while acknowledging inflation and economic outlook uncertainty remain somewhat elevated. In October 2025, the Federal Reserve announced an additional 25 basis point reduction, setting the federal funds rate target range to 3.75% to 4.00%. In addition, the Federal Reserve announced that it will end the balance sheet reduction program, which began in 2022, effective December 1, 2025. The Federal Reserve noted that it will continue to monitor economic data and adjust its stance on monetary policy if risks emerge that could negatively impact the attainment of its goal of maximum employment and inflation at 2% over the long term.
Risks related to changes in interest rates are disclosed in our 2024 Form 10-K in “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements,” “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates and sustained high interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals and surrenders” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk.”
Summary of Critical Accounting Estimates
The MD&A included in our 2024 Form 10-K contains a detailed discussion of our critical accounting estimates. The following information updates the “Summary of Critical Accounting Estimates” provided in our 2024 Form 10-K, and therefore, should be read in conjunction with that disclosure.
Investments
Investment Valuation
The following summarizes investments on the Consolidated Balance Sheets carried at fair value by pricing source and fair value hierarchy level (in millions) as of September 30, 2025:
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total Fair Value | |
|---|---|---|---|---|
| Priced by third-party pricing services | $839 | $78,417 | $158 | $79,414 |
| Priced by independent broker quotations | – | – | 6,762 | 6,762 |
| Priced by matrices | – | 17,294 | – | 17,294 |
| Priced by other methods (1) | – | – | 343 | 343 |
| Total | $839 | $95,711 | $7,263 | $103,813 |
| Percent of total | 1% | 92% | 7% | 100% |
(1) Represents primarily securities for which pricing models were used to compute fair value.
For more information about the valuation of our financial instruments carried at fair value, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Summary of Critical Accounting Estimates – Investments – Investment Valuation” in our 2024 Form 10-K and Note 13 herein.
Derivatives
Derivatives are primarily used for hedging purposes. We hedge certain portions of our exposure to interest rate risk, foreign currency exchange risk, equity market risk, basis risk, commodity risk and credit risk by entering into derivative transactions. We also purchase and issue financial instruments that contain embedded derivative instruments. See “Policyholder Account Balances” below for information on embedded derivatives. Assessing the effectiveness of hedging and evaluating the carrying values of the related derivatives often involve a variety of assumptions and estimates
We carry our derivative instruments at fair value, which we determine through valuation techniques or models that use market data inputs or independent broker quotations. The fair values fluctuate from period to period due to the volatility of the valuation inputs, including but not limited to swap interest rates, interest and equity volatility and equity index levels, foreign currency forward and spot rates, credit spreads and correlations, some of which are significantly affected by economic conditions. The effect to revenue is reported in realized gain (loss) and such amount along with the associated federal income taxes is excluded from income (loss) from operations of our segments.
For more information on derivatives, see Note 1 in our 2024 Form 10-K and Note 5 herein. For more information on market exposures associated with our derivatives, including sensitivities, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K.
Future Contract Benefits
Future contract benefits represent liability reserves that we have established and carry based on estimates of how much we will need to pay for future benefits and claims.
Liability for Future Policy Benefits
Liability for future policy benefits (“LFPB”) represents the reserve amounts associated with non-participating traditional life insurance contracts and limited payment life-contingent annuity contracts that are calculated to meet the various policy and contract obligations as they mature. Establishing adequate reserves for our obligations to policyholders requires assumptions to be made that are intended to represent an estimation of experience for the period that policy benefits are payable. If actual experience is better than or equal to the assumptions, then reserves should be adequate to provide for future benefits and expenses. If experience is worse than the assumptions, additional reserves may be required. Significant assumptions include mortality rates, morbidity and policyholder behavior (e.g., persistency) and withdrawals. During the third quarter of each year, we conduct our comprehensive review of the actuarial assumptions to best estimate future premium and benefit cash flows (“cash flow assumptions”) and projection models used in estimating these liabilities and update these assumptions as needed (excluding the claims settlement expense assumption that is locked-in at inception) in the calculation of the net premium ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. See “Annual Assumption Review” below for more information. In measuring our LFPB, we establish cohorts, which are groupings of long-duration contracts. On a quarterly basis, we retrospectively update the net premium ratio at the cohort level for actual experience. For all contract cohorts issued after January 1, 2021, interest is accrued on LFPB at the single-A interest rate on the contract cohort inception date. For contract cohorts issued prior to January 1, 2021, interest remains accruing at the original discount rate in effect on the contract cohort inception date due to the modified retrospective transition method. We also remeasure the LFPB using the single-A interest rate as of the end of each reporting period.
Liability for Future Claims
Future contract benefits include reserves for long-term disability and life waiver claims associated with our Group Protection segment. These reserves use actuarial assumptions primarily based on claim termination rates, mortality rates, offsets for other insurance including social security, morbidity, incidence and severity assumptions. Such cash flow assumptions are subject to the comprehensive review process discussed above. We remeasure the liability for future claims using a single-A interest rate as of the end of each reporting period. See “Annual Assumption Review” below for more information.
Additional Liabilities for Other Insurance Benefits
We previously issued UL-type contracts where we provided a secondary guarantee to the policyholder. The policy can remain in force, even if the base policy account balance is zero, as long as contractual secondary guarantee requirements have been met. These guaranteed benefits require an additional liability that is calculated based on the application of a benefit ratio (calculated as the present value of total expected benefit payments over the life of the contract from inception divided by the present value of total expected assessments over the life of the contract). These secondary guarantees are reported within future contract benefits on the Consolidated Balance Sheets. The level and direction of the change in reserves will vary over time based on the emergence of the benefit ratio and the level of assessments associated with the contracts. Cash flow assumptions incorporated in a benefit ratio in measuring these additional liabilities for other insurance benefits include mortality rates, morbidity, policyholder behavior (e.g., persistency) and withdrawals based principally on generally accepted actuarial methods and assumptions. During the third quarter of each year, we conduct our comprehensive review of the cash flow assumptions and projection models used in estimating these liabilities and update these assumptions in the calculation of the benefit ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. See “Annual Assumption Review” below for more information.
For additional information on future contract benefits, see Note 11.
Market Risk Benefits
MRBs are contracts or contract features that provide protection to the policyholder from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk upon the occurrence of a specific event or circumstance, such as death, annuitization or periodic withdrawal. An MRB can be in either an asset or a liability position. Our MRB assets and MRB liabilities are reported at fair value separately on the Consolidated Balance Sheets.
We issue variable and fixed annuity contracts that may include various types of guaranteed living benefit (“GLB”) and guaranteed death benefit (“GDB”) riders that we have accounted for as MRBs. For contracts that contain multiple riders that qualify as MRBs, the MRBs are valued on a combined basis using an integrated model. We have entered into reinsurance agreements to cede certain GLB and GDB riders where the reinsurance agreements themselves are accounted for as MRBs or contain MRBs. We therefore record ceded MRB assets and ceded MRB liabilities associated with these reinsurance agreements. We report ceded MRBs associated with these reinsurance agreements in other assets or other liabilities on the Consolidated Balance Sheets.
Net amount at risk (“NAR”) represents the amount of GLB or GDB in excess of a policyholder’s account balance at the balance sheet date. Underperforming markets increase our exposure to potential benefits with the GLB and GDB riders. A contract with a GDB rider is “in the money” if the policyholder’s account balance falls below the GDB. As of September 30, 2025 and 2024, 3% and 5%, respectively, of all in-force contracts with a GDB rider were “in the money.” A contract with a GLB rider is “in the money” if the policyholder’s account balance falls below the present value of GLB payments, assuming no full surrenders. As of September 30, 2025 and 2024, 12% and 13%, respectively, of all in-force contracts with a GLB rider were “in the money.” However, the only way the policyholder can realize the excess of the present value of benefits over the account balance of the contract is through a series of withdrawals or income payments that do not exceed a maximum amount. If, after the series of withdrawals or income payments, the account balance is exhausted, the policyholder will continue to receive a series of annuity payments. The account balance can also fluctuate with market returns on a daily basis resulting in increases or decreases in the excess of the present value of benefits over account balance.
Many policyholders have both a GLB and GDB present on the same policy. The total NAR represents the greater of GLB NAR and GDB NAR for each policy as only one benefit can be exercised in practice. Details underlying the NAR, net of reinsurance, (in millions) were as follows:
| Annuities As of September 30, 2025 | 2024 | Retirement Plan Services As of September 30, 2025 | 2024 | |
|---|---|---|---|---|
| GLB NAR | $1,256 | $1,236 | $1 | $1 |
| GDB NAR | 454 | 540 | 1 | 2 |
| Total NAR | 1,676 | 1,721 | 2 | 3 |
The change in the fair value of MRB assets and liabilities is reported in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss), except for the portion attributable to the change in non-performance risk, which is recognized in other comprehensive income (loss) (“OCI”). The change in the fair value of ceded MRB assets and liabilities, including the changes in our counterparties’ non-performance risks, is reported in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our non-performance risk. Ceded MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our counterparties’ non-performance risk. The scenario assumptions, at each valuation date, are those we view to be appropriate for a hypothetical market participant and include assumptions for capital markets, lapse, benefit utilization, mortality, risk margin and administrative expenses. These assumptions are based on a combination of historical data and actuarial judgments. The assumption for our own non-performance risk and our counterparties’ non-performance risk for MRBs and ceded MRBs, respectively, are determined at each valuation date and reflect our risk and our counterparties’ risks of not fulfilling the obligations of the underlying liability. The spread for the non-performance risk is added to the discount rates used in determining the fair value from the net cash flows. We believe these assumptions are consistent with those that would be used by a market participant; however, as the related markets develop, we will continue to reassess our assumptions. During the third quarter of each year, we conduct our comprehensive review of the assumptions used in calculating the fair value of these MRBs and update these assumptions on a prospective basis as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. For information on fair value inputs, see Note 13. See “Annual Assumption Review” below for more information.
For illustrative purposes, the following presents hypothetical effects to MRBs attributable to changes to key assumptions / inputs, assuming all other factors remain constant:
| Hypothetical | Hypothetical | |||
|---|---|---|---|---|
| Effect | Effect | |||
| Assumption / Input | Actual Experience | to MRB Liability | to Net Income | Description of Assumption / Input |
| Equity market return | Increase / (Decrease) | (Decrease) / Increase | Increase / (Decrease) | Equity market return input represents impact based on movements in equity markets. |
| Interest rate | Higher / Lower | (Decrease) / Increase | Increase / (Decrease) | Interest rate input represents impact based on movements in interest rates and impact to fixed-income assets. |
| Volatility | Increase / (Decrease) | Increase / (Decrease) | (Decrease) / Increase | Volatility assumption represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Volatility assumptions vary by fund due to the benchmarking of difference indices. |
| Mortality | Increase / (Decrease) | (Decrease) / Increase | Increase / (Decrease) | Mortality represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die. |
| Mortality contracts with only GDB rider | Increase / (Decrease) | Increase / (Decrease) | (Decrease) / Increase | Mortality represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die. |
| Lapse | Higher / Lower | (Decrease) / Increase | Increase / (Decrease) | Lapse assumption represents the estimated probability of a contract surrendering during a year, thereby forgoing any future benefits. |
| Benefit utilization | Higher / Lower | Increase / (Decrease) | (Decrease) / Increase | Benefit utilization assumption of guaranteed withdrawals represents the estimated percentage of policyholders that utilize the guaranteed withdrawal feature. |
We use derivative instruments to hedge our exposure to selected risk caused by changes in equity markets and interest rates associated with GLB and GDB riders that are available in our variable annuity products and accounted for as MRBs. Our hedge program focuses on generating sufficient income to fund future claims with a goal of maximizing distributable earnings and explicitly protecting capital. We utilize options and total return swaps on U.S.-based equity indices, and futures on U.S.-based and international equity indices, as well as interest rate futures, interest rate swaps and currency futures. For additional information on our derivatives, see Note 5.
As part of our hedge program, equity market and interest rate conditions are monitored on a daily basis. We rebalance our hedge positions based upon changes in these factors as needed. While we actively manage our hedge positions, these positions may not completely offset changes in the fair value of our GLB and GDB riders caused by movements in these factors due to, among other things, differences in timing between when a market exposure changes and corresponding changes to the hedge positions, extreme swings in the equity markets, interest rates and market-implied volatilities, realized market volatility, policyholder behavior, divergence between the performance of the underlying funds and the hedging indices, divergence between the actual and expected performance of the hedge instruments or our ability to purchase hedging instruments at prices consistent with our desired risk and return trade-off.
The following table presents our after-tax estimates of the potential instantaneous effect to net income (loss) that could result from sudden changes that may occur in equity markets and interest rates (in millions) and excludes the net cost of operating the hedge program. The amounts represent the difference between the change in GLB and GDB riders and the change in the fair value of the underlying hedge instruments. These estimates are based upon the balance as of September 30, 2025, net of reinsurance, and the related hedge instruments in place as of that date.
The effects presented in the table below are not representative of the aggregate impacts that could result if a combination of such changes to equity market returns and interest rates occurred.
| In-Force Sensitivities | ||
|---|---|---|
| Equity Market Return | -10% | +10% |
| Hypothetical effect to net income | $(825) | $725 |
| Interest Rates | -25 bps | +25 bps |
| Hypothetical effect to net income | $(400) | $375 |
The actual effects of the results illustrated in the table above could vary significantly depending on a variety of factors, many of which are out of our control, and consideration should be given to the following:
- The analysis is only valid as of September 30, 2025, due to changing market conditions, policyholder activity, hedge positions and other factors;
- The analysis assumes instantaneous shifts in the capital market factors and no ability to rebalance hedge positions prior to the market changes;
- The analysis assumes constant exchange rates and implied dividend yields;
- Assumptions regarding shifts in the market factors, such as assuming parallel shifts in interest rates, may be overly simplistic and not indicative of actual market behavior in stress scenarios;
- It is very unlikely that one capital market sector (e.g., equity markets) will sustain such a large instantaneous movement without affecting other capital market sectors; and
- The analysis assumes that there is no tracking or basis risk between the funds and/or indices affecting the GLB and GDB riders and the instruments utilized to hedge these exposures.
For additional information on MRBs, see Note 8.
Policyholder Account Balances
Policyholder account balances include the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability includes universal life insurance (“UL”), MoneyGuard®, variable universal life insurance (“VUL”), indexed universal life insurance (“IUL”), investment-type annuity (including registered index-linked annuities (“RILA”)), individual and group fixed and fixed portion of variable annuities, fixed indexed deferred annuities and non-life contingent payout fixed annuities) and funding agreement products where account balances are equal to deposits plus interest credited less withdrawals, surrender charges, asset-based fees and policyholder administration charges (collectively known as “policyholder assessments”), as well as amounts representing the fair value of embedded derivative instruments associated with our fixed indexed annuity and IUL products. During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models underlying our reserves and embedded derivatives and update assumptions as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. See “Annual Assumption Review” below for more information.
Our indexed annuity and IUL contracts permit the holder to elect a fixed interest rate return or a return where interest credited to the contracts is linked to the performance of the S&P 500® Index or other indices. The value of the variable portion of the policyholder’s account balance varies with the performance of the underlying variable funds chosen by the policyholder. Policyholders may elect to rebalance among the various accounts within the product at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing different participation rates, caps, spreads or specified rates, subject to contractual guarantees. We purchase and sell index options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period. The mark-to-market of the options held generally offsets the change in value of the embedded derivative within the contract, both of which are recorded as a component of realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). The Derivatives and Hedging and the Fair Value Measurements and Disclosures Topics of the Financial Accounting Standards Board Accounting Standards CodificationTM
require that we calculate fair values of index options we may purchase or sell in the future to hedge policyholder index allocations in future reset periods. These fair values represent an estimate of the cost of the options we will purchase or sell in the future, discounted back to the date of the balance sheet, using current market indicators of volatility and interest rates. Changes in the fair values of these liabilities are included as a component of realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). For more information on indexed product derivative results, see Note 17.
For additional information on the liability for policyholder account balances, see Note 10.
Reinsurance Recoverables
Reinsurance recoverables are generally measured and recognized consistent with the assumptions and methodologies used to project the future performance of the underlying direct business as discussed in the “Future Contract Benefits” and “Policyholder Account Balances” sections above. During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models and update assumptions as needed. See “Annual Assumption Review” below for more information. In addition, we consider the potential impact of counterparty credit risks related to the reinsurance recoverable by estimating an allowance for credit losses using a probability of loss model approach to estimate expected credit losses for reinsurance recoverables. For additional information on our allowance for credit losses on reinsurance-related assets, see Note 7 in our 2024 Form 10-K.
Annual Assumption Review
During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models used in estimating MRBs, our reserves and embedded derivatives. For more information on our comprehensive review, see Note 1 in our 2024 Form 10-K. Details underlying the impact to net income (loss) from our annual assumption review (in millions) were as follows:
| Income (loss) from operations: | For the Three Months Ended September 30, 2025 | 2024 |
|---|---|---|
| Annuities | $(8) | $1 |
| Life Insurance | (29) | 8 |
| Group Protection | 39 | (1) |
| Retirement Plan Services | – | – |
| Excluded from income (loss) from operations | (52) | 208 |
| Net income (loss) | $(50) | $216 |
The impacts of our annual assumption review were driven primarily by the following:
2025
- For Annuities, the unfavorable impact was driven by model enhancements and updates to policyholder behavior assumptions.
- For Life Insurance, the unfavorable impact was driven by updates to mortality assumptions for our UL products with secondary guarantees and policyholder behavior assumptions, partially offset by updates to mortality assumptions for our traditional life insurance business and morbidity assumptions.
- For Group Protection, the favorable impact was driven by updates to the claim termination rate assumption, partially offset by updates to social security and incurred assumptions and other items.
- For excluded from income (loss) from operations, the unfavorable impact, related to net annuity product features, was driven by updates to policyholder behavior assumptions, model enhancements and other items, partially offset by updates to separate account fee assumptions.
2024
- For Life Insurance, the favorable impact was driven by updates to capital market assumptions on reinsured blocks of MoneyGuard® business and other items, partially offset by unfavorable updates to policyholder behavior assumptions on reinsured blocks of MoneyGuard business.
- For Group Protection, the unfavorable impact was driven by updates to disability claim termination rate assumptions, partially offset by favorable updates to life waiver incurred assumptions.
- For excluded from income (loss) from operations, the favorable impact, related to net annuity product features, was driven by model enhancements.
Goodwill
During the fourth quarter of 2025, we will perform our annual quantitative goodwill impairment test as of October 1, 2025, on all of our reporting units. For more information on goodwill, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Summary of Critical Accounting Estimates – Goodwill and Other Intangible Assets” and Notes 1 and 8 in our 2024 Form 10-K.
Income Taxes
Management uses certain assumptions and estimates in determining the income taxes payable or refundable for the current year, the deferred income tax assets and liabilities for items recognized differently in its financial statements from amounts shown on its income tax returns and the federal income tax expense. Determining these amounts requires analysis and interpretation of current tax laws and regulations. Management exercises judgment in evaluating the amount and timing of recognition of the resulting income tax assets and liabilities. These judgments and estimates are re-evaluated on a continual basis as regulatory and business factors change. Legislative changes to the Internal Revenue Code of 1986, as amended, modifications or new regulations, administrative rulings, or court decisions could increase or decrease our effective tax rate.
The application of GAAP requires us to evaluate the recoverability of our deferred tax assets and establish a valuation allowance, if necessary, to reduce our deferred tax asset to an amount that is more likely than not to be realizable. Judgment and the use of estimates are required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, we consider many factors, including: the nature and character of the deferred tax assets and liabilities; taxable income in prior carryback years; future reversals of existing temporary differences; the length of time carryovers can be utilized; and any future prudent and feasible tax planning strategies.
As of September 30, 2025, we had an approximate $1.7 billion deferred tax asset related to net unrealized losses on fixed maturity available-for-sale (“AFS”) securities. In the assessment of the future realizability of this deferred tax asset, management concluded that its tax planning strategies, including holding these securities to recovery, were prudent and feasible as these unrealized losses were caused by factors other than credit loss, and we have the intent and ability to hold these securities to recovery and collect all of the contractual cash flows.
Although realization is not assured, management believes it is more likely than not that the deferred tax assets, will be realized.
For risks related to establishing a valuation allowance against our deferred tax assets, see “Part I – Item 1A. Risk Factors – Assumptions and Estimates – We may be required to recognize an impairment of our goodwill or to establish a valuation allowance against our deferred tax assets” in our 2024 Form 10-K.
For additional information on income taxes, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Summary of Critical Accounting Estimates – Income Taxes” and Note 23 in our 2024 Form 10-K and Note 18 herein.
RESULTS OF CONSOLIDATED OPERATIONS
Details underlying the consolidated results (in millions) were as follows:
| Net Income (Loss) Income (loss) from operations: | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Annuities | $310 | $301 | $886 | $857 |
| Life Insurance | 25 | 22 | 40 | (48) |
| Group Protection | 149 | 109 | 423 | 318 |
| Retirement Plan Services | 46 | 44 | 116 | 120 |
| Other Operations | (99) | (84) | (282) | (276) |
| Net annuity product features, pre-tax (1) | 410 | (381) | (277) | 1,319 |
| Net life insurance product features, pre-tax | (22) | (125) | (37) | (253) |
| Credit loss-related adjustments, pre-tax | (38) | (88) | (91) | (124) |
| Investment gains (losses), pre-tax | (35) | (105) | (218) | (416) |
| Changes in the fair value of reinsurance-related | ||||
| embedded derivatives, trading securities and | ||||
| certain mortgage loans, pre-tax (2) | (191) | (446) | (266) | (51) |
| Gains (losses) on other non-financial assets – sale of | ||||
| subsidiaries/businesses, pre-tax (3) | – | (2) | – | 582 |
| Other items, pre-tax (4)(5)(6)(7)(8) | (105) | (19) | (65) | (238) |
| Income tax benefit (expense) related to the | ||||
| above pre-tax items | (5) | 246 | 194 | (202) |
| Net income (loss) | $445 | $(528) | $423 | $1,588 |
(1) For the three months ended September 30, 2025 and 2024, includes changes in MRBs of $337 million and $(666) million, respectively; changes in the fair value of the related hedge instruments inclusive of income allocated to support the cost of hedging or future benefits of $30 million and $188 million, respectively; and changes in the fair value of the embedded derivative liabilities and the associated index options for our indexed annuity products of $43 million and $97 million, respectively. For the nine months ended September 30, 2025 and 2024, includes changes in MRBs of $(33) million and $1,354 million, respectively; changes in the fair value of the related hedge instruments inclusive of income allocated to support the cost of hedging or future benefits of $(307) million and $(350) million, respectively; and changes in the fair value of the embedded derivative liabilities and the associated index options for our indexed annuity products of $63 million and $315 million, respectively.
(2) Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. The coinsurance with funds withheld investment portfolio includes fixed maturity securities classified as AFS with changes in fair value recorded in OCI. Since the corresponding and offsetting changes in fair value of the embedded derivative related to the coinsurance with funds withheld investment portfolio are recorded in realized gain (loss), volatility can occur within net income (loss). See Note 7 for more information.
(3) For information on the sale of our wealth management business, see Note 1 in our 2024 Form 10-K.
(4) Includes certain legal accruals of $(9) million for the three and nine months ended September 30, 2025; and $(114) million for the nine months ended September 30, 2024, primarily related to the settlement of cost of insurance litigation in the first quarter of 2024.
(5) Includes severance expense related to initiatives to realign the workforce of $(5) million and $(16) million for the three months ended September 30, 2025 and 2024, respectively, and $(13) million and $(72) million for the nine months ended September 30, 2025 and 2024, respectively.
(6) Includes transaction, integration and other costs related to mergers, acquisitions, divestitures and certain other corporate initiatives consisting of $(55) million of transaction costs related to restructuring certain captive reinsurance subsidiaries and $(22) million related to Life Insurance segment persistency optimization for the three months ended September 30, 2025; $(2) million related to the sale of our wealth management business for the three months ended September 30, 2024; for the nine months ended September 30, 2025, includes $(55) million of transaction costs related to restructuring certain captive reinsurance subsidiaries, $(22) million related to Life Insurance segment persistency optimization, $(20) million related to the sale of our wealth management business and $(18) million primarily related to the Bain Capital transaction; for the nine months ended September 30, 2024, includes $(39) million primarily related to the sale of our wealth management business.
(7) Includes deferred compensation mark-to-market adjustment of $(14) million and $(1) million for the three months ended September 30, 2025 and 2024, respectively, and $(22) million and $(13) million for the nine months ended September 30, 2025 and 2024, respectively.
(8) Includes gains on early extinguishment of debt of $94 million for the nine months ended September 30, 2025.
Comparison of the Three Months Ended September 30, 2025 to 2024
Net income increased due primarily to the following:
- Gain in net annuity product features in 2025 compared to loss in 2024 driven by the impact of capital markets.
- Lower unfavorable changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans driven by the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction.
- Lower loss in net life insurance product features driven by the change in the fair value of hedges associated with VUL products attributable to the impact of capital markets.
- Lower investment losses driven by gains in 2025 on certain investments associated with the fourth quarter 2023 reinsurance transaction compared to losses in 2024 and lower realized losses on certain investments.
- Lower credit loss-related adjustments on our mortgage loans on real estate.
The increase in net income was partially offset by the following:
- Unfavorable impact from our annual assumption review in 2025 compared to favorable impact in 2024.
- Higher net unfavorable other items driven by transaction costs related to restructuring certain captive reinsurance subsidiaries and persistency optimization in our Life Insurance segment in 2025.
Comparison of the Nine Months Ended September 30, 2025 to 2024
Net income decreased due primarily to the following:
- Loss in net annuity product features in 2025 compared to gain in 2024 driven by the impact of capital markets.
- Gain on other non-financial assets in 2024 due to the sale of our wealth management business.
- Unfavorable impact from our annual assumption review in 2025 compared to favorable impact in 2024.
- Higher unfavorable changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans driven by the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction.
The decrease in net income was partially offset by the following:
- Lower loss in net life insurance product features driven by the change in the fair value of hedges associated with VUL products attributable to the impact of capital markets.
- Lower investment losses driven by favorable changes in the fair value of certain derivatives, higher gains on certain investments associated with the fourth quarter 2023 reinsurance transaction and lower realized losses on certain investments.
- Lower net unfavorable other items driven by gain on extinguishment of debt in 2025 and settlement of cost of reinsurance litigation in 2024, partially offset by transaction costs related to restructuring certain captive reinsurance subsidiaries and persistency optimization in our Life Insurance segment in 2025.
- Improvement in our total loss ratio in our Group Protection segment and growth in average account balances.
- Higher investment income on alternative investments.
See “Summary of Critical Accounting Estimates – Annual Assumption Review” above for information on the impacts from our annual assumption review.
RESULTS OF ANNUITIES
Details underlying the results for Annuities (in millions) were as follows:
| Operating Revenues | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Insurance premiums (1) | $25 | $38 | $75 | $98 |
| Fee income | 617 | 601 | 1,782 | 1,769 |
| Net investment income | 497 | 442 | 1,449 | 1,297 |
| Other revenues (2) | 131 | 114 | 376 | 509 |
| Total operating revenues | 1,270 | 1,195 | 3,682 | 3,673 |
| Operating Expenses | ||||
| Benefits and policyholder liability remeasurement (1) | 24 | 38 | 84 | 105 |
| Interest credited | 459 | 399 | 1,317 | 1,129 |
| Commissions and other expenses | 419 | 399 | 1,235 | 1,411 |
| Total operating expenses | 902 | 836 | 2,636 | 2,645 |
| Income (loss) from operations before taxes | 368 | 359 | 1,046 | 1,028 |
| Federal income tax expense (benefit) | 58 | 58 | 160 | 171 |
| Income (loss) from operations | $310 | $301 | $886 | $857 |
(1) Insurance premiums include primarily our income annuities that have a corresponding offset in benefits and policyholder liability remeasurement. Benefits and policyholder liability remeasurement include primarily changes in income annuity reserves driven by insurance premiums.
(2) Consists primarily of revenues attributable to the net settlement related to certain reinsurance transactions, which has a corresponding offset in net investment income and interest credited; and broker-dealer services, which are subject to market volatility and have a comparable offset in commissions and other expenses. During the second quarter of 2024, we closed the sale of our wealth management business. For more information, see Note 1 in our 2024 Form 10-K.
Comparison of the Three Months Ended September 30, 2025 to 2024
Income from operations for this segment increased due to higher fee income driven by higher average daily separate account balances.
The increase in income from operations was partially offset by the following:
- Higher commissions and other expenses, driven by the impact from our annual assumption review and higher deferred acquisition costs (“DAC”) amortization.
- Lower net investment income, net of interest credited, in certain reinsured portfolios and lower investment income within our surplus portfolio, which more than offset impacts from higher average general account balances and improving portfolio yields from the current interest rate environment. The lower net investment income, net of interest credited in certain reinsured portfolios had a corresponding increase in other revenues.
Comparison of the Nine Months Ended September 30, 2025 to 2024
Income from operations for this segment increased due primarily to:
- Higher fee income driven by higher average daily separate account balances.
- Lower federal income tax expense due to more unfavorable separate account dividends-received deduction true-ups in 2024.
The increase in income from operations was partially offset by the following:
- Higher commissions and other expenses, net of broker-dealer expenses, driven by higher DAC amortization and the impact from our annual assumption review.
- Lower net investment income, net of interest credited, in certain reinsured portfolios and lower investment income within our surplus portfolio, which more than offset impacts from higher average general account balances and improving portfolio yields from the current interest rate environment. The lower net investment income, net of interest credited, in certain reinsured portfolios had a corresponding increase in other revenues.
The increase in income from operations was also due to higher commissions and other expenses in the first quarter of 2024 related to a balance sheet true-up in preparation for the close of the sale of the wealth management business.
See “Summary of Critical Accounting Estimates – Annual Assumption Review” above for information on the impacts from our annual assumption review.
Additional Information
New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations.
The other component of net flows relates to the retention of new business and account balances. An important measure of retention is the reduction in account balances caused by full surrenders, deaths and other contract benefits. These outflows as a percentage of average gross account balances were 11% for the three and nine months ended September 30, 2025 and 2024.
Our fixed annuities and RILA have discretionary fixed and indexed crediting rates that reset on an annual or periodic basis and may be subject to surrender charges. Our ability to retain these annuities will be subject to current competitive conditions at the time crediting rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements,” “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates and sustained high interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals and surrenders” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Industry Trends – Interest Rate Environment” in our 2024 Form 10-K.
Fee Income
Details underlying fee income (in millions) were as follows:
| Fee Income | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Mortality, expense and other assessments (1) | $602 | $586 | $1,738 | $1,718 |
| Surrender charges | 13 | 14 | 38 | 46 |
| DFEL: | ||||
| Deferrals | (4) | (5) | (12) | (14) |
| Amortization | 6 | 6 | 18 | 19 |
| Total fee income | $617 | $601 | $1,782 | $1,769 |
(1) Presented net of GLB and GDB hedge allowance.
We charge policyholders mortality and expense assessments on variable annuity accounts to cover insurance and administrative expenses. These assessments are a function of the rates priced into the product and the average daily separate account balances. Average daily separate account balances are driven by net flows and variable fund returns. Charges on GLB riders are assessed based on a contractual rate that is applied either to the account balance or the guaranteed amount. We allocate a portion of these fees to support the cost of hedging GLB and GDB riders. For more information, see Note 15. We may collect surrender charges when our fixed and variable annuity policyholders surrender their contracts during the surrender charge period to protect us from premature withdrawals.
Net Investment Income and Interest Credited
Details underlying net investment income and interest credited (in millions) were as follows:
| Net Investment Income Fixed maturity AFS securities, mortgage loans on real | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| estate and other, net of investment expenses | $464 | $397 | $1,342 | $1,175 |
| Commercial mortgage loan prepayment and bond | ||||
| make-whole premiums (1) | 3 | – | 5 | 1 |
| Surplus investments (2) | 30 | 45 | 102 | 112 |
| Net investment income pertaining to broker-dealer services | – | – | – | 9 |
| Total net investment income | $497 | $442 | $1,449 | $1,297 |
| Interest Credited | ||||
| Amount provided to policyholders | $457 | $396 | $1,309 | $1,120 |
| DSI deferrals | – | – | (1) | (1) |
| Interest credited before DSI amortization | 457 | 396 | 1,308 | 1,119 |
| DSI amortization | 2 | 3 | 9 | 10 |
| Total interest credited | $459 | $399 | $1,317 | $1,129 |
(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
A portion of our investment income earned is credited to the policyholders of our deferred fixed annuities, the fixed portion of our variable annuities and our RILA contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuities, fixed portion of the variable annuities and RILA contracts and what we credit to our policyholders’ accounts. Changes in commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Account Balances
Details underlying account balances (dollars in millions) were as follows:
| Separate Account Balance Information (1) | As of or For the Three Months Ended September 30, 2025 | 2024 | As of or For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Separate account deposits | $1,561 | $1,076 | $4,392 | $3,002 |
| Separate account net flows | (2,705) | (2,509) | (7,557) | (7,189) |
| Separate account balances | 123,428 | 120,469 | 123,428 | 120,469 |
| Average daily separate account balances | 121,539 | 117,913 | 117,988 | 116,270 |
| Average daily S&P 500® Index (2) | 6,427 | 5,546 | 6,020 | 5,266 |
| General Account Balance Information | ||||
| General account deposits | $2,909 | $2,307 | $7,901 | $7,054 |
| General account net flows | 1,562 | 872 | 3,576 | 2,605 |
| General account balances (3) | 50,651 | 44,688 | 50,651 | 44,688 |
| Average general account balances (3) | 48,779 | 43,767 | 46,747 | 41,975 |
(1) Excludes the fixed portion of variable annuities and RILA indexed account balances.
(2) We generally use the S&P 500 Index as a benchmark for the performance of our separate account balances. The account balances of our variable annuity contracts are invested by our policyholders in a variety of investment options including, but not limited to, domestic and international equity securities and fixed income, which do not necessarily align with S&P 500 Index performance.
(3) Net of reinsurance.
For more information on account balances, see Notes 9 and 10.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
| Commissions and Other Expenses Commissions: | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Deferrable | $152 | $109 | $407 | $294 |
| Non-deferrable | 175 | 176 | 510 | 514 |
| General and administrative expenses | 130 | 122 | 381 | 358 |
| Expenses associated with reserve financing | ||||
| and LOC expenses | 5 | 5 | 18 | 15 |
| Taxes, licenses and fees | 3 | 9 | 25 | 32 |
| Total expenses incurred, excluding broker-dealer | 465 | 421 | 1,341 | 1,213 |
| DAC deferrals | (174) | (129) | (464) | (342) |
| Total pre-broker-dealer expenses incurred, | ||||
| excluding amortization | 291 | 292 | 877 | 871 |
| DAC, VOBA and other amortization: | ||||
| Amortization | 116 | 109 | 346 | 322 |
| Impact from annual assumption review | 12 | (2) | 12 | (2) |
| Broker-dealer expenses incurred (1) | – | – | – | 220 |
| Total commissions and other expenses | $419 | $399 | $1,235 | $1,411 |
| DAC Deferrals | ||||
|---|---|---|---|---|
| As a percentage of sales/deposits | 3.9% | 3.8% | 3.8% | 3.4% |
(1) During the second quarter of 2024, we closed the sale of our wealth management business. For more information, see Note 1 in our 2024 Form 10-K.
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain types of commissions, such as trail commissions that are based on account balances, are expensed as incurred rather than deferred and amortized.
RESULTS OF LIFE INSURANCE
Details underlying the results for Life Insurance (in millions) were as follows:
| Operating Revenues | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Insurance premiums (1) | $260 | $286 | $810 | $866 |
| Fee income | 683 | 672 | 2,069 | 2,021 |
| Net investment income | 623 | 601 | 1,803 | 1,724 |
| Operating realized gain (loss) | (1) | (2) | (4) | (5) |
| Other revenues | 45 | 32 | 120 | 34 |
| Total operating revenues | 1,610 | 1,589 | 4,798 | 4,640 |
| Operating Expenses | ||||
| Benefits and policyholder liability remeasurement | 961 | 937 | 2,919 | 2,886 |
| Interest credited | 298 | 302 | 874 | 894 |
| Commissions and other expenses | 327 | 329 | 979 | 939 |
| Total operating expenses | 1,586 | 1,568 | 4,772 | 4,719 |
| Income (loss) from operations before taxes | 24 | 21 | 26 | (79) |
| Federal income tax expense (benefit) | (1) | (1) | (14) | (31) |
| Income (loss) from operations | $25 | $22 | $40 | $(48) |
(1) Includes term insurance premiums, which have a corresponding partial offset in benefits and policyholder liability remeasurement for changes in reserves. The decrease in insurance premiums in the third quarter of 2025 was driven by the expiration of a 10-year assumed reinsurance treaty in the first quarter of 2025, which has a corresponding offset in benefits and policyholder liability remeasurement.
Comparison of the Three and Nine Months Ended September 30, 2025 to 2024
Income from operations for this segment increased due primarily to the following:
- Higher net investment income, net of interest credited, driven by growth in investments and moderate spread expansion.
- Higher fee income driven by higher deferred front-end loads (“DFEL”) amortization.
- Lower commissions and other expenses, net of amortization of deferred loss on business sold through reinsurance, due to expense management.
The increase in income from operations for this segment was partially offset by higher benefits and policyholder liability remeasurement driven by the impact from our annual assumption review and aging of the block, partially offset by improved mortality due to lower claims incidence.
Additionally, for the nine months ended September 30, 2025, the increase in income from operations was driven by higher net investment income, net of interest credited, due to higher investment income on alternative investments.
See “Summary of Critical Accounting Estimates – Annual Assumption Review” above for information on the impacts from our annual assumption review.
Additional Information
For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements,” “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates and sustained high interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals and surrenders” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s
Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Industry Trends – Interest Rate Environment” in our 2024 Form 10-K.
Insurance Premiums
Insurance premiums relate to traditional products and are a function of the rates priced into the product and insurance in force. Insurance in force, in turn, is driven by sales, persistency and mortality claims.
Fee Income
Details underlying fee income, sales, net flows, account balances and in-force face amount (in millions) were as follows:
| Fee Income | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Cost of insurance assessments | $528 | $520 | $1,612 | $1,572 |
| Expense assessments | 381 | 355 | 1,076 | 1,041 |
| Surrender charges | 9 | 6 | 30 | 23 |
| DFEL: | ||||
| Deferrals | (317) | (281) | (890) | (826) |
| Amortization | 84 | 73 | 243 | 212 |
| Impact from annual assumption review | (2) | (1) | (2) | (1) |
| Total fee income | $683 | $672 | $2,069 | $2,021 |
| Sales by Product | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| IUL/UL | $25 | $32 | $78 | $75 |
| MoneyGuard® | 31 | 35 | 89 | 93 |
| VUL | 26 | 22 | 56 | 64 |
| Term | 15 | 15 | 42 | 52 |
| Executive Benefits | 201 | 18 | 251 | 35 |
| Total sales | $298 | $122 | $516 | $319 |
| Net Flows | ||||
| Deposits | $2,247 | $1,262 | $4,747 | $3,699 |
| Withdrawals and deaths | (588) | (524) | (1,886) | (1,469) |
| Net flows | $1,659 | $738 | $2,861 | $2,230 |
| Policyholder Assessments | $1,365 | $1,377 | $4,065 | $4,125 |
101
| Account Balances (1) | As of September 30, 2025 2024 | |
|---|---|---|
| General account | $21,350 $21,391 | |
| Separate account | 28,424 23,328 | |
| Total account balances | $49,774 $44,719 | |
| In-Force Face Amount | ||
| UL and other | $361,964 $364,766 | |
| Term insurance | 705,069 717,071 | |
| Total in-force face amount | $1,067,033 $1,081,837 | |
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | |
| 2025 2024 | 2025 2024 | |
| Average General Account Balances (1) | $21,325 $21,386 | $21,318 $21,392 |
(1) Net of reinsurance ceded.
Fee income relates only to interest-sensitive products and includes cost of insurance assessments, expense assessments and surrender charges. Both cost of insurance and expense assessments can have deferrals and amortization related to DFEL. Cost of insurance and expense assessments are deducted from our policyholders’ account balances. These amounts are a function of the rates priced into the product and premiums received, face amount in force and account balances.
Sales are not recorded as a component of revenues (other than for traditional products) and do not have a significant effect on current quarter income from operations but are indicators of future profitability. Generally, we have higher sales during the second half of the year with the fourth quarter being our strongest.
Sales in the table above and as discussed above were reported as follows:
- UL, IUL and VUL – first-year commissionable premiums plus 5% of excess premiums received;
- MoneyGuard® linked-benefit products – MoneyGuard (UL) and MoneyGuard Market AdvantageSM (VUL), 150% of commissionable premiums;
- Executive Benefits – insurance and corporate-owned UL and VUL, first-year commissionable premiums plus 5% of excess premium received, and single premium bank-owned UL and VUL, 15% of single premium deposits; and
- Term – 100% of annualized first-year premiums.
We monitor the business environment, including but not limited to the regulatory and interest rate environments, and make changes to our product offerings and in-force products as needed, and as permitted under the terms of the policies, to sustain the future profitability of our segment.
Net Investment Income and Interest Credited
Details underlying net investment income and interest credited (in millions) were as follows:
| Net Investment Income Fixed maturity AFS securities, mortgage loans on real | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| estate and other, net of investment expenses | $473 | $458 | $1,389 | $1,393 |
| Commercial mortgage loan prepayment and bond | ||||
| make-whole premiums (1) | 1 | 4 | 2 | 6 |
| Surplus investments (2) | 49 | 42 | 140 | 113 |
| Other investments (3) | 100 | 97 | 272 | 212 |
| Total net investment income | $623 | $601 | $1,803 | $1,724 |
| Interest Credited | $298 | $302 | $874 | $894 |
(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities.
(3) Includes primarily net investment income earned on our alternative investments portfolio. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
A portion of the investment income earned for this segment is credited to policyholder accounts. Statutory reserves will typically grow at a faster rate than account balances because of reserve requirements. Investments allocated to this segment are based upon the statutory reserve liabilities and are affected by various reserve adjustments, including financing transactions providing relief from reserve requirements. These financing transactions lead to a transfer of investments from this segment to Other Operations. We expect to earn a spread between what we earn on the underlying general account investments and what we credit to our policyholders’ accounts. Investment income partially offsets the earnings effect of the associated growth of our policy reserves. Commercial mortgage loan prepayments and bond make-whole premiums and investment income on alternative investments can vary significantly from period to period due to a number of factors, and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Benefits and Policyholder Liability Remeasurement
Details underlying benefits and policyholder liability remeasurement (dollars in millions) were as follows:
| Benefits and Policyholder Liability Remeasurement | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Death claims direct and assumed | $1,680 | $1,437 | $4,629 | $4,420 |
| Death claims ceded | (713) | (662) | (2,013) | (2,028) |
| Reserves released on death | (317) | (137) | (661) | (445) |
| Net death benefits | 650 | 638 | 1,955 | 1,947 |
| Change in secondary guarantee life insurance product | ||||
| reserves: | ||||
| Change in reserves | 75 | 100 | 281 | 291 |
| Impact from annual assumption review | 165 | 20 | 165 | 20 |
| Change in MoneyGuard® reserves: | ||||
| Change in reserves | 160 | 149 | 473 | 419 |
| Impact from annual assumption review | (4) | 53 | (4) | 53 |
| Change in traditional product reserves: | ||||
| Change in reserves | 13 | 29 | 43 | 117 |
| Impact from annual assumption review | (129) | (84) | (129) | (84) |
| Other benefits (1) | 31 | 32 | 135 | 123 |
| Total benefits and policyholder liability remeasurement | $961 | $937 | $2,919 | $2,886 |
| Death claims per $1,000 of in-force | 2.43 | 2.36 | 2.43 | 2.39 |
(1) Includes primarily long-term care claims and life surrender benefits.
Benefits for this segment include claims incurred during the period in excess of the associated reserves for its interest-sensitive and traditional products. In addition, benefits include the change in secondary guarantee, linked-benefit and term life insurance product reserves. These reserves are affected by changes in expected future trends of assessments and benefits causing remeasurements. Generally, we experience higher mortality in the first quarter of the year due to the seasonality of claims.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
| Commissions and Other Expenses | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Commissions | $119 | $120 | $329 | $346 |
| General and administrative expenses | 134 | 138 | 397 | 421 |
| Expenses associated with reserve financing | 25 | 25 | 77 | 72 |
| Taxes, licenses and fees | 41 | 35 | 109 | 103 |
| Total expenses incurred | 319 | 318 | 912 | 942 |
| DAC and VOBA deferrals | (144) | (140) | (387) | (406) |
| Total expenses recognized before amortization | 175 | 178 | 525 | 536 |
| DAC and VOBA amortization: | ||||
| Amortization | 125 | 126 | 378 | 376 |
| Impact from annual assumption review | 2 | – | 2 | – |
| Amortization of deferred loss on business sold | ||||
| through reinsurance | 24 | 24 | 71 | 24 |
| Other intangible amortization | 1 | 1 | 3 | 3 |
| Total commissions and other expenses | $327 | $329 | $979 | $939 |
| DAC and VOBA Deferrals | ||||
|---|---|---|---|---|
| As a percentage of sales | 48.3% | 114.8% | 75.0% | 127.3% |
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable. For our interest-sensitive and traditional products, DAC and value of business acquired (“VOBA”) are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances.
RESULTS OF GROUP PROTECTION
Details underlying the results for Group Protection (in millions) were as follows:
| Operating Revenues | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Insurance premiums | $1,352 | $1,288 | $4,109 | $3,871 |
| Net investment income | 98 | 87 | 281 | 261 |
| Other revenues (1) | 57 | 57 | 176 | 167 |
| Total operating revenues | 1,507 | 1,432 | 4,566 | 4,299 |
| Operating Expenses | ||||
| Benefits and policyholder liability remeasurement | 923 | 919 | 2,830 | 2,790 |
| Interest credited | 1 | 1 | 1 | 3 |
| Commissions and other expenses | 395 | 375 | 1,199 | 1,103 |
| Total operating expenses | 1,319 | 1,295 | 4,030 | 3,896 |
| Income (loss) from operations before taxes | 188 | 137 | 536 | 403 |
| Federal income tax expense (benefit) | 39 | 28 | 113 | 85 |
| Income (loss) from operations | $149 | $109 | $423 | $318 |
(1) Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.
| Income (Loss) from Operations by Product Line | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Life | $71 | $37 | $120 | $56 |
| Disability | 81 | 75 | 311 | 269 |
| Dental | (3) | (3) | (8) | (7) |
| Income (loss) from operations | $149 | $109 | $423 | $318 |
Comparison of the Three and Nine Months Ended September 30, 2025 to 2024
Income from operations for this segment increased due primarily to the following:
- Higher insurance premiums due to growth in business in force and persistency.
- Higher net investment income, net of interest credited, driven by growth in business in force.
The increase in income from operations was partially offset by the following:
- Higher commissions and other expenses due to incentive compensation as a result of production performance.
- Higher benefits and policyholder liability remeasurement driven by less favorable claims experience than expected in our disability business and growth in business in force, partially offset by the impact of the annual assumption review, lower claims severity and incidence in our life business and lower incidence in our disability business.
See “ Summary of Critical Accounting Estimates – Annual Assumption Review” for information on the impacts from our annual assumption review.
Additional Information
For information about the effect of the loss ratio sensitivity on our income (loss) from operations, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Group Protection – Additional Information” in our 2024 Form 10-K.
For information on the effects of current interest rates on our long-term disability claim reserves, see “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2024 Form 10-K.
Insurance Premiums
Details underlying insurance premiums (in millions) were as follows:
| Insurance Premiums by Product Line | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Life | $531 | $505 | $1,613 | $1,504 |
| Disability | 774 | 739 | 2,356 | 2,229 |
| Dental | 47 | 44 | 140 | 138 |
| Total insurance premiums | $1,352 | $1,288 | $4,109 | $3,871 |
| Sales by Product Line | ||||
| Life | 50 | 42 | $255 | $208 |
| Disability | 47 | 36 | 165 | 161 |
| Dental | 19 | 6 | 40 | 20 |
| Total sales | $116 | $84 | $460 | $389 |
Premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.
Sales relate to new policyholders and new coverages sold to existing policyholders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products. Generally, we have higher sales during the fourth quarter of the year.
Net Investment Income
We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:
| Net Investment Income Fixed maturity AFS securities, mortgage loans on real estate | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| and other, net of investment expenses | $79 | $65 | $221 | $203 |
| Commercial mortgage loan prepayment and bond | ||||
| make-whole premiums (1) | – | 1 | 1 | 1 |
| Surplus investments (2) | 19 | 21 | 59 | 57 |
| Total net investment income | $98 | $87 | $281 | $261 |
(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
Benefits and Policyholder Liability Remeasurement
Details underlying benefits and policyholder liability remeasurement (in millions) and loss ratios by product line were as follows:
| Benefits and Policyholder Liability Remeasurement by Product Line | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Life | $316 | $343 | $1,087 | $1,102 |
| Disability | 571 | 541 | 1,633 | 1,584 |
| Dental | 37 | 36 | 111 | 107 |
| Total benefits and policyholder liability | ||||
| remeasurement by product line | $924 | $920 | $2,831 | $2,793 |
| Loss Ratios by Product Line | ||||
| Life | 59.6% | 68.1% | 67.4% | 73.2% |
| Disability | 73.8% | 73.2% | 69.3% | 71.1% |
| Dental | 78.0% | 79.0% | 79.1% | 78.1% |
| Total | 68.3% | 71.4% | 68.9% | 72.2% |
Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. For additional information on our loss ratios, see “Additional Information” above.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
| Commissions and Other Expenses | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Commissions | $132 | $114 | $404 | $336 |
| General and administrative expenses | 225 | 219 | 674 | 653 |
| Taxes, licenses and fees | 34 | 35 | 106 | 106 |
| Other | 1 | 1 | 3 | 3 |
| Total expenses incurred | 392 | 369 | 1,187 | 1,098 |
| DAC deferrals | (36) | (30) | (103) | (101) |
| Total expenses recognized before amortization | 356 | 339 | 1,084 | 997 |
| DAC and other intangible amortization | 39 | 36 | 115 | 106 |
| Total commissions and other expenses | $395 | $375 | $1,199 | $1,103 |
| DAC Deferrals | ||||
|---|---|---|---|---|
| As a percentage of insurance premiums | 2.7% | 2.3% | 2.5% | 2.6% |
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized.
RESULTS OF RETIREMENT PLAN SERVICES
Details underlying the results for Retirement Plan Services (in millions) were as follows:
| Operating Revenues | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Fee income | $77 | $74 | $221 | $216 |
| Net investment income | 257 | 253 | 760 | 744 |
| Other revenues (1) | 9 | 8 | 20 | 24 |
| Total operating revenues | 343 | 335 | 1,001 | 984 |
| Operating Expenses | ||||
| Interest credited | 174 | 170 | 518 | 505 |
| Commissions and other expenses | 116 | 116 | 349 | 342 |
| Total operating expenses | 290 | 286 | 867 | 847 |
| Income (loss) from operations before taxes | 53 | 49 | 134 | 137 |
| Federal income tax expense (benefit) | 7 | 5 | 18 | 17 |
| Income (loss) from operations | $46 | $44 | $116 | $120 |
(1) Consists primarily of mutual fund account program revenues from mid to large employers.
Comparison of the Three Months Ended September 30, 2025 to 2024
Income from operations for this segment increased due primarily to higher fee income driven by higher average daily separate account balances.
Comparison of the Nine Months Ended September 30, 2025 to 2024
Income from operations for this segment decreased due primarily to the following:
- Higher commissions and other expenses driven by higher trail commissions resulting from higher average daily separate account balances.
- Lower other revenues due to a plan termination during the fourth quarter of 2024.
The decrease in income from operations was partially offset by the following:
- Higher fee income driven by higher average daily separate account balances.
- Higher net investment income, net of interest credited, driven by higher investment income on prepayment and bond make-whole premiums, higher average general account balances and impacts to portfolio yields from the current interest rate environment, partially offset by an increase in crediting rates.
Additional Information
Net flows in this business fluctuate based on the timing of larger plans being implemented and terminating over the course of the year.
New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations. The other component of net flows relates to the retention of the business. An important measure of retention is the reduction in account balances caused by plan sponsor terminations and participant withdrawals. These outflows as a percentage of average account balances were 14% and 17% for the three and nine months ended September 30, 2025, and 13% for the corresponding periods in 2024. The increase in the outflow rate for the nine months ended September 30, 2025, was attributable primarily to a large plan termination during the first quarter of 2025.
Our net flows are negatively affected by the continued net outflows from our oldest blocks of annuities business (as presented on our Net Flows By Market table below as “Multi-Fund® and other”), which are among our higher margin product lines in this segment, due to the fact that they are mature blocks with low distribution and servicing costs. The proportion of these products to our total account balances was 12% and 13% as of September 30, 2025 and 2024, respectively. Due to this overall shift in business mix toward products with lower returns, new deposit production continues to be necessary to maintain earnings at current levels.
Our fixed annuity business includes products with discretionary and index-based crediting rates that are reset on either a quarterly or semi-annual basis. Our ability to retain quarterly or semi-annual reset annuities will be subject to current competitive conditions at the time crediting rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows into or out of our fixed accounts or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements,” “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates and sustained high interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals and surrenders” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Industry Trends – Interest Rate Environment” in our 2024 Form 10-K.
Fee Income
Details underlying fee income (in millions) were as follows:
| Fee Income | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Annuity expense assessments | $56 | $54 | $161 | $158 |
| Mutual fund fees | 20 | 19 | 58 | 56 |
| Total expense assessments | 76 | 73 | 219 | 214 |
| Surrender charges | 1 | 1 | 2 | 2 |
| Total fee income | $77 | $74 | $221 | $216 |
Our fee income is primarily composed of expense assessments that we charge to cover insurance and administrative expenses, and mutual fund fees earned for services we provide to our mutual fund programs. Fee income is primarily based on average account balances, both general and separate, which are driven by net flows and the equity markets. Fee income is also driven by non-account balance-related items such as participant counts. We may collect surrender charges when our policyholders surrender their contracts during the surrender charge period to protect us from premature withdrawals.
Net Investment Income and Interest Credited
Details underlying net investment income and interest credited (in millions) were as follows:
| Net Investment Income Fixed maturity AFS securities, mortgage loans on real estate | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| and other, net of investment expenses | $237 | $231 | $701 | $686 |
| Commercial mortgage loan prepayment and | ||||
| bond make-whole premiums (1) | 2 | – | 2 | 1 |
| Surplus investments (2) | 18 | 22 | 57 | 57 |
| Total net investment income | $257 | $253 | $760 | $744 |
| Interest Credited | $174 | $170 | $518 | $505 |
(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
A portion of our investment income earned is credited to the policyholders of our fixed annuity products, including the fixed portion of variable annuity contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuity product line, including the fixed portion of variable annuity contracts, and what we credit to our policyholders’ accounts. Commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Account Balances
Details underlying account balances (dollars in millions) were as follows:
| Separate Account Balance Information (1) | As of or For the Three Months Ended September 30, 2025 | 2024 | As of or For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Separate account deposits | $564 | $633 | $1,712 | $1,688 |
| Separate account net flows | (361) | (233) | (1,002) | (680) |
| Separate account balances | 23,071 | 21,985 | 23,071 | 21,985 |
| Average daily separate account balances | 22,582 | 21,272 | 21,702 | 20,688 |
| Average daily S&P 500® Index (2) | 6,427 | 5,546 | 6,020 | 5,266 |
| General Account Balance Information | ||||
| General account deposits | $1,090 | $944 | $3,011 | $2,580 |
| General account net flows | (197) | (151) | (709) | (790) |
| General account balances | 23,852 | 23,727 | 23,852 | 23,727 |
| Average general account balances | 23,787 | 23,604 | 23,638 | 23,605 |
| Mutual Fund Account Balance Information | ||||
| Mutual fund deposits | $3,354 | $2,603 | $7,994 | $6,997 |
| Mutual fund net flows | 1,313 | 1,035 | (303) | 2,315 |
| Mutual fund account balances (3) | 75,829 | 68,084 | 75,829 | 68,084 |
(1) Excludes the fixed portion of variable annuities.
(2) We generally use the S&P 500 Index as a benchmark for the performance of our separate account balances. The account balances of our variable annuity contracts are invested by our policyholders in a variety of investment options including, but not limited to, domestic and international equity securities and fixed income, which do not necessarily align with S&P 500 Index performance.
(3) Mutual funds are not included in the separate accounts reported on the Consolidated Balance Sheets as we do not have any ownership interest in them.
| Net Flows By Market | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Small market | $190 | $11 | $139 | $22 |
| Mid – large market | 1,025 | 1,069 | (908) | 2,122 |
| Multi-Fund® and other | (460) | (429) | (1,245) | (1,299) |
| Total net flows | $755 | $651 | $(2,014) | $845 |
For more information on account balances, see Notes 9 and 10.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
| Commissions and Other Expenses Commissions: | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Deferrable | $1 | $1 | $4 | $4 |
| Non-deferrable | 29 | 27 | 80 | 72 |
| General and administrative expenses | 83 | 85 | 251 | 253 |
| Taxes, licenses and fees | 4 | 3 | 14 | 14 |
| Total expenses incurred | 117 | 116 | 349 | 343 |
| DAC deferrals | (5) | (5) | (14) | (15) |
| Total expenses recognized before amortization | 112 | 111 | 335 | 328 |
| DAC amortization | 4 | 5 | 14 | 14 |
| Total commissions and other expenses | $116 | $116 | $349 | $342 |
| DAC Deferrals | ||||
| As a percentage of annuity sales/deposits | 0.3% | 0.3% | 0.3% | 0.4% |
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain types of commissions, such as trail commissions that are based on account balances, are expensed as incurred rather than deferred and amortized. Distribution expenses associated with the sale of mutual fund products are expensed as incurred.
RESULTS OF OTHER OPERATIONS
Details underlying the results for Other Operations (in millions) were as follows:
| Operating Revenues | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Insurance premiums (1) | $– | $1 | $1 | $4 |
| Net investment income (2) | 33 | 35 | 102 | 79 |
| Other revenues (3) | 17 | 16 | 40 | 35 |
| Total operating revenues | 50 | 52 | 143 | 118 |
| Operating Expenses | ||||
| Benefits and policyholder liability remeasurement | 4 | (3) | 14 | 10 |
| Interest credited | 22 | 8 | 49 | 26 |
| Other expenses | 72 | 66 | 196 | 177 |
| Interest and debt expense | 79 | 86 | 240 | 253 |
| Total operating expenses | 177 | 157 | 499 | 466 |
| Income (loss) from operations before taxes | (127) | (105) | (356) | (348) |
| Federal income tax expense (benefit) | (28) | (21) | (74) | (72) |
| Income (loss) from operations | $(99) | $(84) | $(282) | $(276) |
(1) Includes our disability income business, which has a corresponding offset in benefits and policyholder liability remeasurement for changes in reserves.
(2) Includes our institutional pension business, which has a corresponding offset in premiums and benefits and policyholder liability remeasurement for changes in reserves, and funding agreement activity beginning in 2025, which has a partial offset in interest credited. For information on funding agreements, see Note 10.
(3) Includes certain third-party advisory fees, which has a partial offset in other expenses.
Comparison of the Three Months Ended September 30, 2025 to 2024
Loss from operations for Other Operations increased due primarily to the following:
- Lower net investment income, net of interest credited, related to lower allocated investments driven by a decrease in excess capital retained by Other Operations.
- Higher other expenses associated with other costs pertaining to business operations.
The increase in loss from operations was partially offset by lower interest and debt expense driven by a decline in average outstanding debt and interest rates.
Comparison of the Nine Months Ended September 30, 2025 to 2024
Loss from operations for Other Operations increased due primarily to higher other expenses associated with other costs pertaining to business operations.
The increase in loss from operations was partially offset by the following:
- Lower interest and debt expense driven by a decline in average outstanding debt and interest rates.
- Higher other revenues due to the effect of market fluctuations on assets held as part of certain compensation plans.
Net Investment Income and Interest Credited
We utilize an internal formula to determine the amount of capital that is allocated to our business segments. Investment income on capital in excess of the calculated amounts is reported in Other Operations. If our business segments require increases in statutory reserves, surplus or investments, the amount of excess capital that is retained by Other Operations would decrease and net investment income would be negatively affected.
Write-downs for impairments decrease the recorded value of investments owned by the business segments. These write-downs are not included in the income from operations of our business segments. When impairment occurs, assets are transferred to the business segments’ portfolios and will reduce the future net investment income for Other Operations. Statutory reserve adjustments for our business segments can also cause allocations of investments between the business segments and Other Operations.
The majority of our interest credited relates to our reinsurance operations sold to Swiss Re Life & Health America, Inc. (“Swiss Re”) in 2001. A substantial amount of the business was sold through indemnity reinsurance transactions, which is still recorded in the consolidated financial statements. The interest credited corresponds to investment income earnings on the assets we continue to hold for this business. There is no effect to income or loss in Other Operations or on a consolidated basis for these amounts because interest earned on the blocks that continue to be reinsured is passed through to Swiss Re in the form of interest credited.
Benefits and Policyholder Liability Remeasurement
Benefits are recognized when incurred for institutional pension products and disability income business. Policyholder liability remeasurement gains (losses) result from updates in cash flow assumptions and actual variance from expected experience used in the net premium ratio or benefit ratio calculation for future policy benefits associated with institutional pension products.
Other Expenses
Details underlying other expenses (in millions) were as follows:
| General and administrative expenses: | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Legal | $2 | $2 | $4 | $4 |
| Branding | 12 | 9 | 33 | 32 |
| Other (1) | 51 | 56 | 152 | 151 |
| Total general and administrative expenses | 65 | 67 | 189 | 187 |
| DAC and VOBA deferrals | (2) | – | (7) | – |
| Other (2) | 9 | (1) | 14 | (10) |
| Total other expenses | $72 | $66 | $196 | $177 |
(1) Includes expenses that are corporate in nature and not allocated to our business segments.
(2) Consists primarily of reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of letters of credit (“LOCs”) and taxes, licenses and fees.
Interest and Debt Expense
Our current level of interest expense may not be indicative of the future due to, among other things, the timing of the use of cash and the future cost of capital. For additional information on our financing activities, see “Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Debt” below.
CONSOLIDATED INVESTMENTS
Details underlying consolidated investment balances (in millions) were as follows:
| Investments | As of September 30, 2025 | As of December 31, 2024 | Percentage of Total Investments As of September 30, 2025 | As of December 31, 2024 |
|---|---|---|---|---|
| Fixed maturity AFS securities | $90,680 | $87,111 | 66.6% | 67.1% |
| Trading securities | 1,853 | 2,025 | 1.4% | 1.6% |
| Equity securities | 542 | 294 | 0.4% | 0.2% |
| Mortgage loans on real estate | 22,230 | 21,083 | 16.3% | 16.2% |
| Policy loans | 2,584 | 2,476 | 1.9% | 1.9% |
| Derivative investments | 10,427 | 9,677 | 7.6% | 7.4% |
| Other investments: | ||||
| Alternative investments | 4,144 | 3,836 | 3.0% | 3.0% |
| Alternative investments – reinsurance-related (1) | 1,440 | 1,464 | 1.1% | 1.1% |
| Company-owned life insurance | 1,181 | 664 | 0.9% | 0.5% |
| Other | 1,021 | 1,288 | 0.8% | 1.0% |
| Total investments | $136,102 | $129,918 | 100.0% | 100.0% |
(1) Represents alternative investments that support reinsurance funds withheld and modified coinsurance agreements where the investment results are passed directly to the reinsurers. For more information, see Note 7 in our 2024 Form 10-K.
Investment Objective
Investments are an integral part of our operations. We follow a balanced approach to investing for both current income and prudent risk management, with an emphasis on generating sufficient current income, net of income tax, to meet our obligations to customers, as well as other general liabilities. This balanced approach requires the evaluation of expected return and risk of each asset class utilized, while still meeting our income objectives. This approach is important to our asset-liability management because decisions can be made based upon both the economic and current investment income considerations affecting assets and liabilities. For a discussion of our risk management process, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K.
Investment Portfolio Composition and Diversification
Fundamental to our investment policy is diversification across asset classes. Our investment portfolio, excluding cash and invested cash, is composed of fixed maturity securities, mortgage loans on real estate, real estate (either wholly owned or in joint ventures) and other long-term investments. We purchase investments for our segmented portfolios that have yield, duration and other characteristics that take into account the liabilities of the products being supported.
We have the ability to maintain our investment holdings throughout credit cycles because of our capital position, the long-term nature of our liabilities and the matching of our portfolios of investment assets with the liabilities of our various products.
Fixed Maturity and Equity Securities Portfolios
Fixed maturity securities consist of portfolios classified as AFS and trading. Details underlying our fixed maturity AFS securities by industry classification (in millions) are presented in the tables below. These tables agree in total with the presentation of fixed maturity AFS securities in Note 3; however, the categories below represent a more detailed breakout of the fixed maturity AFS portfolio. Therefore, the investment classifications listed below do not agree to the investment categories provided in Note 3.
| Fixed Maturity AFS Securities Industry corporate bonds: | As of September 30, 2025 Net% Amortized Cost (1) | Gross Unrealized Gains | Losses | Fair Value | Fair Value |
|---|---|---|---|---|---|
| Financial services | $14,324 | $152 | $1,034 | $13,442 | 14.8% |
| Basic industry | 3,278 | 54 | 321 | 3,011 | 3.3% |
| Capital goods | 6,252 | 82 | 590 | 5,744 | 6.3% |
| Communications | 3,178 | 60 | 349 | 2,889 | 3.2% |
| Consumer cyclical | 5,665 | 62 | 464 | 5,263 | 5.8% |
| Consumer non-cyclical | 14,873 | 156 | 2,036 | 12,993 | 14.4% |
| Energy | 3,021 | 40 | 269 | 2,792 | 3.1% |
| Technology | 4,840 | 32 | 500 | 4,372 | 4.8% |
| Transportation | 3,492 | 47 | 310 | 3,229 | 3.6% |
| Industrial other | 2,549 | 17 | 426 | 2,140 | 2.4% |
| Utilities | 12,702 | 136 | 1,471 | 11,367 | 12.5% |
| Government-related entities | 1,303 | 24 | 218 | 1,109 | 1.2% |
| Collateralized mortgage and other obligations (“CMOs”): | |||||
| Agency backed | 1,172 | 4 | 125 | 1,051 | 1.2% |
| Non-agency backed | 364 | 26 | 3 | 387 | 0.4% |
| Mortgage pass through securities (“MPTS”): | |||||
| Agency backed | 704 | 9 | 33 | 680 | 0.7% |
| Commercial mortgage-backed securities (“CMBS”): | |||||
| Non-agency backed | 2,244 | 13 | 107 | 2,150 | 2.4% |
| Asset-backed securities (“ABS”): | |||||
| Collateralized loan obligations (“CLOs”) | 7,852 | 14 | 146 | 7,720 | 8.5% |
| Other (2) | 6,953 | 121 | 88 | 6,986 | 7.7% |
| Municipals: | |||||
| Taxable | 2,570 | 21 | 388 | 2,203 | 2.4% |
| Tax-exempt | 35 | – | 3 | 32 | 0.0% |
| Government: | |||||
| United States | 642 | 8 | 31 | 619 | 0.7% |
| Foreign | 281 | 14 | 51 | 244 | 0.3% |
| Hybrid and redeemable preferred securities | 241 | 24 | 8 | 257 | 0.3% |
| Total fixed maturity AFS securities | 98,535 | 1,116 | 8,971 | 90,680 | 100.0% |
| Trading Securities (3) | 1,933 | 47 | 127 | 1,853 | |
| Equity Securities | 546 | 10 | 14 | 542 | |
| Total fixed maturity AFS, trading and equity securities | $101,014 | $1,173 | $9,112 | $93,075 |
118
| Fixed Maturity AFS Securities Industry corporate bonds: | As of December 31, 2024 Net% Amortized Cost (1) | Gross Unrealized Gains | Losses | Fair Value | Fair Value |
|---|---|---|---|---|---|
| Financial services | $14,276 | $97 | $1,396 | $12,977 | 14.9% |
| Basic industry | 3,395 | 40 | 381 | 3,054 | 3.5% |
| Capital goods | 6,223 | 51 | 745 | 5,529 | 6.4% |
| Communications | 3,242 | 49 | 437 | 2,854 | 3.3% |
| Consumer cyclical | 5,899 | 38 | 593 | 5,344 | 6.1% |
| Consumer non-cyclical | 15,042 | 115 | 2,356 | 12,801 | 14.7% |
| Energy | 3,000 | 27 | 341 | 2,686 | 3.1% |
| Technology | 4,708 | 19 | 620 | 4,107 | 4.7% |
| Transportation | 3,451 | 28 | 370 | 3,109 | 3.6% |
| Industrial other | 2,450 | 7 | 445 | 2,012 | 2.3% |
| Utilities | 12,494 | 76 | 1,750 | 10,820 | 12.4% |
| Government-related entities | 1,362 | 16 | 221 | 1,157 | 1.3% |
| CMOs: | |||||
| Agency backed | 1,202 | 3 | 168 | 1,037 | 1.2% |
| Non-agency backed | 328 | 21 | 4 | 345 | 0.4% |
| MPTS: | |||||
| Agency backed | 529 | – | 48 | 481 | 0.6% |
| CMBS: | |||||
| Non-agency backed | 1,817 | 4 | 156 | 1,665 | 1.9% |
| ABS: | |||||
| CLOs | 8,307 | 21 | 277 | 8,051 | 9.2% |
| Other (2) | 5,895 | 78 | 144 | 5,829 | 6.6% |
| Municipals: | |||||
| Taxable | 2,765 | 18 | 443 | 2,340 | 2.7% |
| Tax-exempt | 33 | – | 2 | 31 | 0.0% |
| Government: | |||||
| United States | 429 | 3 | 41 | 391 | 0.5% |
| Foreign | 282 | 11 | 56 | 237 | 0.3% |
| Hybrid and redeemable preferred securities | 240 | 25 | 11 | 254 | 0.3% |
| Total fixed maturity AFS securities | 97,369 | 747 | 11,005 | 87,111 | 100.0% |
| Trading Securities (3) | 2,168 | 35 | 178 | 2,025 | |
| Equity Securities | 310 | 6 | 22 | 294 | |
| Total fixed maturity AFS, trading and equity securities | $99,847 | $788 | $11,205 | $89,430 |
(1) Represents amortized cost, net of the allowance for credit losses.
(2) Includes securities collateralized by consumer loans, equipment loans and other asset types.
(3) Certain of our trading securities support our reinsurance funds withheld and modified coinsurance agreements and the investment results are passed directly to the reinsurers. See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Fixed Maturity and Equity Securities Portfolios – Trading Securities” in our 2024 Form 10-K for more information.
Fixed Maturity AFS Securities
In accordance with the fixed maturity AFS accounting guidance, we reflect stockholders’ equity as if unrealized gains and losses were actually recognized and consider all related accounting adjustments that would occur upon such a hypothetical recognition of unrealized gains and losses. Such related balance sheet effects include adjustments to future contract benefits, policyholder account balances and deferred income taxes. Adjustments to each of these balances are charged or credited to accumulated other comprehensive income (loss) (“AOCI”). For instance, deferred income tax balances are adjusted because unrealized gains or losses do not affect actual taxes currently paid.
The quality of our fixed maturity AFS securities portfolio, as measured at estimated fair value and by the percentage of fixed maturity AFS securities invested in various ratings categories, relative to the entire fixed maturity AFS security portfolio (in millions) was as follows:
| Rating Agency NAIC Equivalent Designation (1) Designation (1) Investment Grade Securities | As of September 30, 2025 Net Amortized Cost | Fair Value | % of Total | As of December 31, 2024 Net Amortized Cost | Fair Value | % of Total |
|---|---|---|---|---|---|---|
| 1 AAA / AA / A | $59,186 | $53,980 | 59.5% | $58,103 | $51,596 | 59.2% |
| 2 BBB | 36,294 | 33,711 | 37.2% | 36,224 | 32,583 | 37.4% |
| Total investment grade securities | 95,480 | 87,691 | 96.7% | 94,327 | 84,179 | 96.6% |
| Below Investment Grade Securities | ||||||
| 3 BB | 999 | 949 | 1.0% | 960 | 910 | 1.0% |
| 4 B | 1,880 | 1,870 | 2.1% | 1,857 | 1,826 | 2.1% |
| 5 CCC and lower | 103 | 101 | 0.1% | 138 | 124 | 0.2% |
| 6 In or near default | 73 | 69 | 0.1% | 87 | 72 | 0.1% |
| Total below investment grade securities | 3,055 | 2,989 | 3.3% | 3,042 | 2,932 | 3.4% |
| Total fixed maturity AFS securities | $98,535 | $90,680 | 100.0% | $97,369 | $87,111 | 100.0% |
| Total securities below investment grade as a percentage of total | ||||
|---|---|---|---|---|
| fixed maturity AFS securities | 3.1% | 3.3% | 3.1% | 3.4% |
(1) Based upon the rating designations determined and provided by the National Association of Insurance Commissioners (“NAIC”) or the major credit rating agencies (Fitch Ratings (“Fitch”), Moody’s Investors Service (“Moody’s”) and S&P Global Ratings (“S&P”)). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings. The average credit quality was A- as of September 30, 2025.
Comparisons between the NAIC designations and rating agency designations are published by the NAIC. The NAIC assigns securities quality designations and uniform valuations, which are used by insurers when preparing their annual statements. The NAIC designations are similar to the rating agency designations of the Nationally Recognized Statistical Rating Organizations for marketable bonds. NAIC designations 1 and 2 include bonds generally considered investment grade (rated Baa3 or higher by Moody’s, or rated BBB- or higher by S&P and Fitch) by such ratings organizations. However, securities designated NAIC 1 and 2 could be deemed below investment grade by the rating agencies as a result of the current risk-based capital (“RBC”) rules for residential mortgage-backed securities (“RMBS”) and CMBS for statutory reporting. NAIC designations 3 through 6 include bonds generally considered below investment grade (rated Ba1 or lower by Moody’s, or rated BB+ or lower by S&P and Fitch).
As of September 30, 2025, and December 31, 2024, 97% of the total fixed maturity AFS securities in an unrealized loss position were investment grade. Our gross unrealized losses recognized in OCI on fixed maturity AFS securities as of September 30, 2025, decreased by $2.0 billion since December 31, 2024. For the nine months ended September 30, 2025, we recognized $190 million of gross losses, on fixed maturity AFS securities, which were primarily related to sales that support our reinsurance funds withheld agreements where the investment results are passed directly to the reinsurers. For the nine months ended September 30, 2024, we recognized $204 million of gross losses on fixed maturity AFS securities, which were primarily related to portfolio rebalancing and sales that support our reinsurance funds withheld agreements where the investment results are passed directly to the reinsurers.
We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require a credit allowance. We do not believe the unrealized loss position as of September 30, 2025, required an impairment recognized in earnings as: (i) we did not intend to sell these fixed maturity AFS securities; (ii) it is not more likely than not that we will be required to sell the fixed maturity AFS securities before recovery of their amortized cost basis; and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. This conclusion is consistent with our asset-liability management process. Management considered the following as part of the evaluation:
- The current economic environment and market conditions;
- Our business strategy and current business plans;
- The nature and type of security, including expected maturities and exposure to general credit, liquidity, market and interest rate risk;
- Our analysis of data from financial models and other internal and industry sources to evaluate the current effectiveness of our hedging and overall risk management strategies;
- The current and expected timing of contractual maturities of our assets and liabilities, expectations of prepayments on investments and expectations for surrenders and withdrawals of annuity contracts and life insurance policies;
- The capital risk limits approved by management; and
- Our current financial condition and liquidity demands.
We recognized $(18) million and $(65) million of credit loss benefit (expense) on our fixed maturity AFS securities for the three and nine months ended September 30, 2025, respectively, and $(14) million and $(40) million, respectively, for the corresponding periods in 2024. In order to determine the amount of credit loss, we calculated the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows we expect to recover. To determine the recoverability, we considered the facts and circumstances surrounding the underlying issuer including, but not limited to, the following:
- Historical and implied volatility of the security;
- The extent to which the fair value has been less than amortized cost;
- Adverse conditions specifically related to the security or to specific conditions in an industry or geographic area;
- Failure, if any, of the issuer of the security to make scheduled payments; and
- Recoveries or additional declines in fair value subsequent to the balance sheet date.
For information on credit loss impairment on fixed maturity AFS securities, see Notes 3 and 16 herein and Note 1 in our 2024 Form 10-K.
As reported on the Consolidated Balance Sheets, we had $146.8 billion of investments and cash and invested cash, which exceeded the liabilities for our future obligations under insurance policies and contracts, net of amounts recoverable from reinsurers and amounts on deposit with reinsurers, which totaled $117.2 billion as of September 30, 2025. If it were necessary to liquidate fixed maturity AFS securities prior to maturity or call to meet cash flow needs, we would first look to those fixed maturity AFS securities that are in an unrealized gain position, which had a fair value of $31.8 billion as of September 30, 2025, rather than selling fixed maturity AFS securities in an unrealized loss position. The amount of cash that we have on hand at any point in time takes into account our liquidity needs in the future, other sources of cash, such as the maturities of investments, interest and dividends we earn on our investments and the ongoing cash flows from new and existing business. For additional information, see “Liquidity and Capital Resources” below.
As of September 30, 2025, and December 31, 2024, the estimated fair value for all private placement securities was $22.4 billion and $20.9 billion, respectively, representing 16% of total investments.
Mortgage-Backed Securities (Included in Fixed Maturity AFS and Trading Securities)
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Mortgage-Backed Securities” in our 2024 Form 10-K for a discussion of our mortgage-backed securities.
The market value of fixed maturity AFS and trading securities backed by subprime loans was $177 million and represented less than 1% of our total investment portfolio as of September 30, 2025. Fixed maturity AFS securities represented $170 million, or 96%, and trading securities represented $7 million, or 4%, of the subprime exposure as of September 30, 2025. The table below summarizes our investments in fixed maturity AFS securities backed by pools of residential mortgages (in millions) as of September 30, 2025:
| Type | Agency Net Amortized Cost | Fair Value | Non-Agency Net Amortized Cost | Fair Value | Total Net Amortized Cost | Fair Value |
|---|---|---|---|---|---|---|
| RMBS | $1,876 | $1,732 | $364 | $386 | $2,240 | $2,118 |
| ABS home equity | – | – | 152 | 188 | 152 | 188 |
| Total by type (1)(2) | $1,876 | $1,732 | $516 | $574 | $2,392 | $2,306 |
| NAIC Designation | ||||||
| 1 | $1,876 | $1,732 | $422 | $475 | $2,298 | $2,207 |
| 2 | – | – | 76 | 75 | 76 | 75 |
| 3 | – | – | 7 | 6 | 7 | 6 |
| 4 | – | – | 9 | 17 | 9 | 17 |
| 5 | – | – | 2 | 1 | 2 | 1 |
| 6 | – | – | – | – | – | – |
| Total by NAIC designation (1)(2)(3) | $1,876 | $1,732 | $516 | $574 | $2,392 | $2,306 |
| Total fixed maturity AFS securities backed by pools of | ||
|---|---|---|
| residential mortgages as a percentage of total fixed maturity AFS securities | 2.4% | 2.5% |
| Total non-agency backed as a percentage of total fixed maturity AFS securities | 0.5% | 0.6% |
(1) Does not include the amortized cost of trading securities totaling $54 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $54 million in trading securities consisted of $15 million agency and $39 million non-agency.
(2) Does not include the fair value of trading securities totaling $48 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $48 million in trading securities consisted of $14 million agency and $34 million non-agency.
The market value of fixed maturity AFS and trading securities backed by subprime loans was $179 million and represented less than 1% of our total investment portfolio as of December 31, 2024. Fixed maturity AFS securities represented $172 million, or 96%, and trading securities represented $7 million, or 4%, of the subprime exposure as of December 31, 2024. The table below summarizes our investments in fixed maturity AFS securities backed by pools of residential mortgages (in millions) as of December 31, 2024:
| Type | Agency Net Amortized Cost | Fair Value | Non-Agency Net Amortized Cost | Fair Value | Total Net Amortized Cost | Fair Value |
|---|---|---|---|---|---|---|
| RMBS | $1,731 | $1,518 | $328 | $345 | $2,059 | $1,863 |
| ABS home equity | – | – | 159 | 189 | 159 | 189 |
| Total by type (1)(2) | $1,731 | $1,518 | $487 | $534 | $2,218 | $2,052 |
| NAIC Designation | ||||||
| 1 | $1,731 | $1,518 | $460 | $502 | $2,191 | $2,020 |
| 2 | – | – | 6 | 6 | 6 | 6 |
| 3 | – | – | 10 | 9 | 10 | 9 |
| 4 | – | – | 9 | 15 | 9 | 15 |
| 5 | – | – | 2 | 2 | 2 | 2 |
| 6 | – | – | – | – | – | – |
| Total by NAIC designation (1)(2)(3) | $1,731 | $1,518 | $487 | $534 | $2,218 | $2,052 |
| Total fixed maturity AFS securities backed by pools of | ||
|---|---|---|
| residential mortgages as a percentage of total fixed maturity AFS securities | 2.3% | 2.4% |
| Total non-agency backed as a percentage of total fixed maturity AFS securities | 0.5% | 0.6% |
(1) Does not include the amortized cost of trading securities totaling $64 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $64 million in trading securities consisted of $15 million agency and $49 million non-agency.
(2) Does not include the fair value of trading securities totaling $54 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $54 million in trading securities consisted of $14 million agency and $40 million non-agency.
None of these investments as of September 30, 2025, and December 31, 2024, included any direct investments in subprime lenders or mortgages. We are not aware of material exposure to subprime loans in our alternative investment portfolio as of September 30, 2025, and December 31, 2024.
The following summarizes our investments in fixed maturity AFS securities backed by pools of commercial mortgages (in millions) as of September 30, 2025:
| Type | Multiple Property Net Amortized Cost | Fair Value | Single Property Net Amortized Cost | Fair Value | Total Net Amortized Cost | Fair Value | ||
|---|---|---|---|---|---|---|---|---|
| CMBS (1)(2) | $2,046 | $1,955 | $198 | $195 | $2,244 | $2,150 | ||
| NAIC Designation | ||||||||
| 1 | $2,011 | $1,922 | $198 | $195 | $2,209 | $2,117 | ||
| 2 | 35 | 33 | – | – | 35 | 33 | ||
| 3 | – | – | – | – | – | – | ||
| 4 | – | – | – | – | – | – | ||
| 5 | – | – | – | – | – | – | ||
| 6 | – | – | — | – | – | — | – | – |
| Total by NAIC designation (1)(2)(3) | $2,046 | $1,955 | $198 | $195 | $2,244 | $2,150 |
| Total fixed maturity AFS securities backed by pools of | ||
|---|---|---|
| commercial mortgages as a percentage of total fixed maturity AFS securities | 2.3% | 2.4% |
(1) Does not include the amortized cost of trading securities totaling $129 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $129 million in trading securities consisted of $80 million of multiple property CMBS and $49 million of single property CMBS.
(2) Does not include the fair value of trading securities totaling $114 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $114 million in trading securities consisted of $73 million of multiple property CMBS and $41 million of single property CMBS.
The following summarizes our investments in fixed maturity AFS securities backed by pools of commercial mortgages (in millions) as of December 31, 2024:
| Type | Multiple Property Net Amortized Cost | Fair Value | Single Property Net Amortized Cost | Fair Value | Total Net Amortized Cost | Fair Value |
|---|---|---|---|---|---|---|
| CMBS (1)(2) | $1,672 | $1,526 | $145 | $139 | $1,817 | $1,665 |
| NAIC Designation | ||||||
| 1 | $1,667 | $1,522 | $145 | $139 | $1,812 | $1,661 |
| 2 | 5 | 4 | – | – | 5 | 4 |
| 3 | – | – | – | – | – | – |
| 4 | – | – | – | – | – | – |
| 5 | – | – | – | – | – | – |
| 6 | – | – | – | – | – | – |
| Total by NAIC designation (1)(2)(3) | $1,672 | $1,526 | $145 | $139 | $1,817 | $1,665 |
| Total fixed maturity AFS securities backed by pools of | ||
|---|---|---|
| commercial mortgages as a percentage of total fixed maturity AFS securities | 1.9% | 1.9% |
(1) Does not include the amortized cost of trading securities totaling $126 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $126 million in trading securities consisted of $77 million of multiple property CMBS and $49 million of single property CMBS.
(2) Does not include the fair value of trading securities totaling $109 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $109 million in trading securities consisted of $68 million of multiple property CMBS and $41 million of single property CMBS.
The following summarizes our investments in ABS within fixed maturity AFS securities (in millions) as of September 30, 2025:
| Type | CLOs Net Amortized Cost | Fair Value | Other Net Amortized Cost | Fair Value | Total Net Amortized Cost | Fair Value | ||
|---|---|---|---|---|---|---|---|---|
| ABS (1)(2) | $7,852 | $7,720 | $6,953 | $6,986 | $14,805 | $14,706 | ||
| NAIC Designation | ||||||||
| 1 | $7,398 | $7,266 | $5,197 | $5,239 | $12,595 | $12,505 | ||
| 2 | 454 | 454 | 1,645 | 1,634 | 2,099 | 2,088 | ||
| 3 | – | – | 36 | 36 | 36 | 36 | ||
| 4 | – | – | 6 | 14 | 6 | 14 | ||
| 5 | – | – | – | – | – | – | ||
| 6 | – | – | – | 69 | 63 | – | 69 | 63 |
| Total by NAIC designation (1)(2)(3) | $7,852 | $7,720 | $6,953 | $6,986 | $14,805 | $14,706 |
(1) Does not include the amortized cost of trading securities totaling $322 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $322 million in trading securities consisted of $210 million of CLOs and $112 million of Other ABS.
(2) Does not include the fair value of trading securities totaling $319 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $319 million in trading securities consisted of $209 million of CLOs and $110 million of Other ABS.
(3) Based upon the rating designations determined and provided by the NAIC.
The following summarizes our investments in ABS within fixed maturity AFS securities (in millions) as of December 31, 2024:
| Type | CLOs Net Amortized Cost | Fair Value | Other Net Amortized Cost | Fair Value | Total Net Amortized Cost | Fair Value | ||
|---|---|---|---|---|---|---|---|---|
| ABS (1)(2) | $8,307 | $8,051 | $5,895 | $5,829 | $14,202 | $13,880 | ||
| NAIC Designation | ||||||||
| 1 | $8,106 | $7,848 | $4,453 | $4,425 | $12,559 | $12,273 | ||
| 2 | 201 | 203 | 1,354 | 1,325 | 1,555 | 1,528 | ||
| 3 | – | – | – | – | – | – | ||
| 4 | – | – | 6 | 13 | 6 | 13 | ||
| 5 | – | – | – | – | – | – | ||
| 6 | – | – | – | 82 | 66 | – | 82 | 66 |
| Total by NAIC designation (1)(2)(3) | $8,307 | $8,051 | $5,895 | $5,829 | $14,202 | $13,880 |
(1) Does not include the amortized cost of trading securities totaling $378 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $378 million in trading securities consisted of $240 million of CLOs and $138 million of Other ABS.
(2) Does not include the fair value of trading securities totaling $369 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $369 million in trading securities consisted of $240 million of CLOs and $129 million of Other ABS.
Composition by Industry Categories of our Unrealized Losses on Fixed Maturity AFS Securities
When considering unrealized gain and loss information, it is important to recognize that the information relates to the position of securities at a particular point in time and may not be indicative of the position of our investment portfolios subsequent to the balance sheet date. Further, because the timing of the recognition of realized investment gains and losses through the selection of which securities are sold is largely at management’s discretion, it is important to consider the information provided below within the context of the overall unrealized gain or loss position of our investment portfolios. These are important considerations that should be included in any evaluation of the potential effect of securities in an unrealized loss position on our future earnings. The composition by industry categories of all fixed maturity AFS securities in an unrealized loss position (in millions) as of September 30, 2025, was as follows:
| Net Amortized Cost | % Net Amortized Cost | Gross Unrealized Losses | % Gross Unrealized Losses | Fair Value | % Fair Value | |
|---|---|---|---|---|---|---|
| Healthcare | $5,657 | 8.3% | $1,151 | 12.8% | $4,506 | 7.7% |
| Electric | 6,587 | 9.7% | 995 | 11.1% | 5,592 | 9.5% |
| Technology | 3,527 | 5.2% | 499 | 5.6% | 3,028 | 5.1% |
| Food and beverage | 3,343 | 4.9% | 479 | 5.3% | 2,864 | 4.9% |
| Industrial – other | 1,991 | 2.9% | 434 | 4.8% | 1,557 | 2.6% |
| Local authorities | 2,081 | 3.1% | 397 | 4.4% | 1,684 | 2.9% |
| Pharmaceuticals | 2,026 | 3.0% | 266 | 3.0% | 1,760 | 3.0% |
| Banking | 3,832 | 5.6% | 264 | 2.9% | 3,568 | 6.1% |
| Diversified manufacturing | 2,026 | 3.0% | 260 | 2.9% | 1,766 | 3.0% |
| Natural gas | 1,492 | 2.2% | 243 | 2.7% | 1,249 | 2.1% |
| ABS | 5,449 | 8.0% | 230 | 2.6% | 5,219 | 8.9% |
| Retail | 1,437 | 2.1% | 213 | 2.4% | 1,224 | 2.1% |
| Chemicals | 1,726 | 2.5% | 211 | 2.4% | 1,515 | 2.6% |
| Brokerage asset management | 1,467 | 2.2% | 184 | 2.1% | 1,283 | 2.2% |
| Property and casualty | 1,217 | 1.8% | 178 | 2.0% | 1,039 | 1.8% |
| Life insurance | 1,193 | 1.8% | 173 | 1.9% | 1,020 | 1.7% |
| Transportation services | 1,730 | 2.6% | 171 | 1.9% | 1,559 | 2.6% |
| Aerospace and defense | 1,164 | 1.7% | 166 | 1.9% | 998 | 1.7% |
| Utility – other | 1,077 | 1.6% | 166 | 1.9% | 911 | 1.5% |
| Government sponsored | 425 | 0.6% | 158 | 1.8% | 267 | 0.5% |
| Railroads | 798 | 1.2% | 136 | 1.5% | 662 | 1.1% |
| Wirelines | 798 | 1.2% | 133 | 1.4% | 665 | 1.1% |
| Midstream | 1,198 | 1.8% | 131 | 1.4% | 1,067 | 1.8% |
| Consumer products | 766 | 1.1% | 109 | 1.2% | 657 | 1.1% |
| Non-agency CMBS | 1,439 | 2.1% | 106 | 1.2% | 1,333 | 2.3% |
| Integrated | 598 | 0.9% | 104 | 1.2% | 494 | 0.8% |
| Wireless | 661 | 1.0% | 101 | 1.1% | 559 | 0.9% |
| Industries with unrealized losses | ||||||
| less than $100 million | 12,129 | 17.9% | 1,313 | 14.6% | 10,816 | 18.4% |
| Total by industry | $67,834 | 100.0% | $8,971 | 100.0% | $58,862 | 100.0% |
| Total by industry as a percentage of | |||
|---|---|---|---|
| total fixed maturity AFS securities | 68.8% | 100.0% | 64.9% |
127
The composition by industry categories of all fixed maturity AFS securities in an unrealized loss position (in millions) as of December 31, 2024, was as follows:
| Net Amortized Cost | % Net Amortized Cost | Gross Unrealized Losses | % Gross Unrealized Losses | Fair Value | % Fair Value | |
|---|---|---|---|---|---|---|
| Healthcare | $5,802 | 7.5% | $1,255 | 11.3% | $4,547 | 6.8% |
| Electric | 7,301 | 9.4% | 1,187 | 10.8% | 6,114 | 9.2% |
| Technology | 3,988 | 5.1% | 621 | 5.6% | 3,367 | 5.1% |
| Food and beverage | 3,603 | 4.6% | 556 | 5.1% | 3,047 | 4.6% |
| Industrial – other | 2,086 | 2.7% | 451 | 4.1% | 1,635 | 2.5% |
| Local authorities | 2,306 | 3.0% | 451 | 4.1% | 1,855 | 2.8% |
| Banking | 5,015 | 6.5% | 419 | 3.8% | 4,596 | 6.9% |
| ABS | 6,807 | 8.8% | 406 | 3.7% | 6,401 | 9.6% |
| Pharmaceuticals | 2,267 | 2.9% | 335 | 3.0% | 1,932 | 2.9% |
| Diversified manufacturing | 2,262 | 2.9% | 323 | 2.9% | 1,939 | 2.9% |
| Natural gas | 1,634 | 2.1% | 285 | 2.6% | 1,349 | 2.0% |
| Retail | 1,565 | 2.0% | 261 | 2.4% | 1,304 | 2.1% |
| Chemicals | 1,893 | 2.4% | 248 | 2.3% | 1,645 | 2.5% |
| Brokerage asset management | 1,658 | 2.1% | 239 | 2.2% | 1,419 | 2.1% |
| Property and casualty | 1,376 | 1.8% | 216 | 2.0% | 1,160 | 1.6% |
| Transportation services | 1,922 | 2.5% | 215 | 2.0% | 1,707 | 2.6% |
| Life insurance | 1,274 | 1.7% | 213 | 1.9% | 1,061 | 1.6% |
| Aerospace and defense | 1,357 | 1.8% | 212 | 1.9% | 1,145 | 1.7% |
| Utility – other | 1,164 | 1.5% | 192 | 1.7% | 972 | 1.5% |
| Consumer products | 1,071 | 1.4% | 173 | 1.6% | 898 | 1.4% |
| Midstream | 1,383 | 1.8% | 163 | 1.5% | 1,220 | 1.8% |
| Non-agency CMBS | 1,503 | 1.9% | 155 | 1.4% | 1,348 | 2.0% |
| Wirelines | 857 | 1.1% | 154 | 1.4% | 703 | 1.1% |
| Railroads | 846 | 1.1% | 149 | 1.4% | 697 | 1.0% |
| Government-sponsored | 459 | 0.6% | 144 | 1.3% | 315 | 0.5% |
| Integrated | 682 | 0.9% | 125 | 1.1% | 557 | 0.8% |
| Automotive | 1,463 | 1.9% | 123 | 1.1% | 1,340 | 2.0% |
| Wireless | 712 | 0.9% | 120 | 1.1% | 592 | 0.9% |
| Industries with unrealized losses | ||||||
| less than $100 million | 13,260 | 17.1% | 1,614 | 14.7% | 11,646 | 17.5% |
| Total by industry | $77,516 | 100.0% | $11,005 | 100.0% | $66,511 | 100.0% |
| Total by industry as a percentage of | |||
|---|---|---|---|
| total fixed maturity AFS securities | 79.6% | 100.0% | 76.4% |
128
Mortgage Loans on Real Estate
The following tables summarize key information on mortgage loans on real estate (in millions):
| Credit Quality Indicator | As of September 30, 2025 Commercial | Residential | Total% | |
|---|---|---|---|---|
| Current | $17,642 | $4,596 | $22,238 | 99.3% |
| Delinquent (1) | 22 | 41 | 63 | 0.3% |
| Foreclosure | 3 | 91 | 94 | 0.4% |
| Total mortgage loans on real estate before allowance | 17,667 | 4,728 | 22,395 | 100.0% |
| Allowance for credit losses | (97) | (68) | (165) | |
| Total mortgage loans on real estate | $17,570 | $4,660 | $22,230 |
| Credit Quality Indicator | As of December 31, 2024 Commercial | Residential | Total% | |
|---|---|---|---|---|
| Current | $17,546 | $3,572 | $21,118 | 99.4% |
| Delinquent (1) | 25 | 33 | 58 | 0.3% |
| Foreclosure | – | 59 | 59 | 0.3% |
| Total mortgage loans on real estate before allowance | 17,571 | 3,664 | 21,235 | 100.0% |
| Allowance for credit losses | (99) | (53) | (152) | |
| Total mortgage loans on real estate | $17,472 | $3,611 | $21,083 |
(1) Includes certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers. As of September 30, 2025, and December 31, 2024, the fair value of such commercial mortgage loans on real estate that were in delinquent status was $20 million and $21 million, respectively.
As of September 30, 2025, there were specifically identified impaired commercial and residential mortgage loans with an aggregate carrying value of $35 million and $82 million, respectively, or less than 1% of total mortgage loans on real estate. As of December 31, 2024, there were specifically identified impaired commercial and residential mortgage loans with an aggregate carrying value of $36 million and $58 million, respectively, or less than 1% of total mortgage loans on real estate.
The total outstanding principal and interest on commercial mortgage loans that were two or more payments delinquent, excluding foreclosures, as of September 30, 2025, and December 31, 2024, was $33 million and $34 million, respectively, or less than 1% of total mortgage loans on real estate. The total outstanding principal and interest on residential mortgage loans that were three or more payments delinquent, excluding foreclosures, as of September 30, 2025, and December 31, 2024, was $40 million and $32 million, respectively, or less than 1% of total mortgage loans on real estate.
The carrying value of mortgage loans on real estate by business segment and Other Operations (in millions) was as follows:
| Segment | As of September 30, 2025 | As of December 31, 2024 |
|---|---|---|
| Annuities | $9,841 | $8,783 |
| Life Insurance | 3,367 | 3,527 |
| Group Protection | 1,761 | 1,608 |
| Retirement Plan Services | 5,273 | 5,380 |
| Other Operations | 1,988 | 1,785 |
| Total mortgage loans on real estate | $22,230 | $21,083 |
129
The composition of commercial mortgage loans (in millions) by property type, geographic region and state is shown below as of September 30, 2025:
| Property Type | Carrying Value% | State | Carrying Value% | ||
|---|---|---|---|---|---|
| Apartment | $5,480 | 31.1% | CA | $4,765 | 27.1% |
| Industrial | 5,200 | 29.6% | TX | 1,771 | 10.1% |
| Office building | 3,016 | 17.2% | FL | 1,009 | 5.7% |
| Retail | 2,785 | 15.9% | NY | 895 | 5.1% |
| Other commercial | 821 | 4.7% | PA | 887 | 5.0% |
| Mixed use | 165 | 0.9% | AZ | 872 | 5.0% |
| Hotel/motel | 103 | 0.6% | GA | 656 | 3.7% |
| Total | $17,570 | 100.0% | MD | 650 | 3.7% |
| Geographic Region | WA | 641 | 3.6% | ||
| Pacific | 5,723 | 32.6% | NC | 524 | 3.0% |
| South Atlantic | 3,716 | 21.1% | TN | 504 | 2.9% |
| Middle Atlantic | 2,204 | 12.5% | VA | 432 | 2.5% |
| West South Central | 1,908 | 10.9% | NJ | 421 | 2.4% |
| Mountain | 1,560 | 8.9% | UT | 398 | 2.3% |
| East North Central | 1,068 | 6.1% | OH | 322 | 1.8% |
| East South Central | 601 | 3.4% | OR | 317 | 1.8% |
| West North Central | 437 | 2.5% | IL | 298 | 1.7% |
| New England | 353 | 2.0% | All other states | 2,208 | 12.6% |
| Total | $17,570 | 100.0% | Total | $17,570 | 100.0% |
The composition of commercial mortgage loans (in millions) by property type, geographic region and state is shown below as of December 31, 2024:
| Property Type | Carrying Value% | State | Carrying Value% | ||
|---|---|---|---|---|---|
| Apartment | $5,551 | 31.8% | CA | $4,707 | 26.9% |
| Industrial | 5,033 | 28.8% | TX | 1,693 | 9.7% |
| Office building | 3,077 | 17.6% | FL | 1,011 | 5.8% |
| Retail | 2,754 | 15.8% | AZ | 906 | 5.2% |
| Other commercial | 803 | 4.6% | PA | 899 | 5.1% |
| Mixed use | 145 | 0.8% | NY | 895 | 5.1% |
| Hotel/motel | 109 | 0.6% | WA | 673 | 4.0% |
| Total | $17,472 | 100.0% | MD | 671 | 3.8% |
| Geographic Region | GA | 639 | 3.7% | ||
| Pacific | 5,683 | 32.5% | TN | 533 | 3.1% |
| South Atlantic | 3,683 | 21.1% | NC | 471 | 2.7% |
| Middle Atlantic | 2,199 | 12.6% | VA | 420 | 2.4% |
| West South Central | 1,829 | 10.5% | NJ | 405 | 2.3% |
| Mountain | 1,525 | 8.7% | IL | 339 | 1.9% |
| East North Central | 1,139 | 6.5% | WI | 328 | 1.9% |
| East South Central | 646 | 3.7% | OH | 323 | 1.8% |
| West North Central | 448 | 2.6% | UT | 322 | 1.8% |
| New England | 320 | 1.8% | All other states | 2,237 | 12.8% |
| Total | $17,472 | 100.0% | Total | $17,472 | 100.0% |
130
The following table shows the principal amount (in millions) of our commercial and residential mortgage loans by year in which the principal is contractually obligated to be repaid:
| Principal Repayment Year | As of September 30, 2025 Commercial | Residential | Total% | |
|---|---|---|---|---|
| 2025 | $322 | $238 | $560 | 2.5% |
| 2026 | 1,413 | 563 | 1,976 | 8.8% |
| 2027 | 1,847 | 128 | 1,975 | 8.8% |
| 2028 | 2,222 | 52 | 2,274 | 10.2% |
| 2029 | 1,922 | 55 | 1,977 | 8.9% |
| 2030 and thereafter | 9,980 | 3,589 | 13,569 | 60.8% |
| Total | $17,706 | $4,625 | $22,331 | 100.0% |
See Note 3 for information regarding our loan-to-value and debt-service coverage ratios and our allowance for credit losses.
Alternative Investments
Investment income (loss) on alternative investments by business segment (in millions) was as follows:
| For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Annuities | $2 | $5 | $8 | $8 |
| Life Insurance | 95 | 92 | 258 | 198 |
| Group Protection | 2 | 1 | 5 | 3 |
| Retirement Plan Services | 2 | 2 | 6 | 4 |
| Other Operations | – | – | – | 1 |
| Total (1) | $101 | $100 | $277 | $214 |
(1) Includes net investment income on the alternative investments supporting the required statutory surplus of our insurance businesses, not including alternative investments that support reinsurance funds withheld and modified coinsurance agreements where the investment results are passed directly to the reinsurers.
As of September 30, 2025, and December 31, 2024, alternative investments included investments in 381 and 371 different partnerships, respectively, and the portfolio represented approximately 3% of total investments. These amounts do not include alternative investments that support funds withheld and modified coinsurance reinsurance agreements where the investment results are passed directly to the reinsurers. The partnerships do not represent off-balance sheet financing and generally involve several third-party partners. Some of our partnerships contain capital calls, which require us to contribute capital upon notification by the general partner. These capital calls are contemplated during the initial investment decision and are planned for well in advance of the call date. The capital calls are not material in size and are not material to our liquidity. Alternative investments are accounted for using the equity method of accounting and are included in other investments on the Consolidated Balance Sheets.
Net Investment Income
Details underlying net investment income (in millions) and our investment yield were as follows:
| Net Investment Income | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| Fixed maturity AFS securities | $1,079 | $1,068 | $3,207 | $3,169 |
| Trading securities | 25 | 31 | 76 | 93 |
| Equity securities | 3 | 3 | 8 | 17 |
| Mortgage loans on real estate | 264 | 232 | 774 | 644 |
| Policy loans | 26 | 21 | 77 | 70 |
| Cash and invested cash | 81 | 59 | 189 | 138 |
| Commercial mortgage loan prepayment | ||||
| and bond make-whole premiums (1) | 6 | 5 | 14 | 9 |
| Other investments (2) | 140 | 72 | 374 | 214 |
| Investment income | 1,624 | 1,491 | 4,719 | 4,354 |
| Investment expense | (80) | (75) | (241) | (250) |
| Net investment income | $1,544 | $1,416 | $4,478 | $4,104 |
(1) See “Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2) Includes primarily investment income on alternative investments. See “Alternative Investments” above for additional information.
| Interest Rate Yield Fixed maturity AFS securities, mortgage loans on | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| real estate and other, net of investment expenses | 4.20% | 4.14% | 4.13% | 4.02% |
| Commercial mortgage loan prepayment and | ||||
| bond make-whole premiums | 0.02% | 0.01% | 0.01% | 0.01% |
| Other investments | 0.42% | 0.22% | 0.38% | 0.22% |
| Net investment income yield on invested assets | 4.64% | 4.37% | 4.52% | 4.25% |
We earn investment income on our general account investments supporting our liabilities associated with investment-type annuities (including RILA, individual and group fixed and fixed portion of variable annuities, fixed indexed deferred annuities and non-life contingent payout fixed annuities), UL, MoneyGuard(R), VUL, IUL and funding agreement products. The profitability of our products is affected by our ability to achieve target spreads, or margins, between the interest income earned on the general account assets and the interest credited to the policyholder account balance. The net investment income and the interest rate yield tables above each include commercial mortgage loan prepayments and bond make-whole premiums, alternative investments and contingent interest and standby real estate equity commitments. These items can vary significantly from period to period due to a number of factors and, therefore, can provide results that are not indicative of the underlying trends.
Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums
Prepayment and make-whole premiums are collected when borrowers elect to call or prepay their debt prior to the stated maturity. A prepayment or make-whole premium allows investors to attain the same yield as if the borrower made all scheduled interest payments until maturity. These premiums are designed to make investors indifferent to prepayment.
LIQUIDITY AND CAPITAL RESOURCES
Overview
Liquidity
Liquidity refers to our ability to generate adequate amounts of cash from our normal operations to meet cash requirements with a prudent margin of safety. Our ability to generate and maintain sufficient liquidity depends on the profitability of our businesses, general economic conditions and access to the capital markets and other sources of liquidity and capital as described below.
When considering our liquidity, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, LNC. As a holding company with no operations of its own, LNC is largely dependent upon the dividend capacity of its insurance and other subsidiaries as well as their ability to advance or repay funds to it through inter-company borrowing arrangements, which may be affected by factors influencing the subsidiaries’ capital position, as discussed further below. Based on the sources of liquidity available to us as discussed below, we currently expect to be able to meet the holding company’s ongoing cash needs.
Capital
Capital refers to our long-term financial resources to support the operations of our businesses, to fund long-term growth strategies and to support our operations during adverse conditions. Our ability to generate and maintain sufficient capital depends on the profitability of our businesses, general economic conditions and access to the capital markets and other sources of liquidity and capital as described below.
Disruptions, uncertainty or volatility in the capital and credit markets may materially affect our business operations and results of operations and may adversely affect our subsidiaries’ capital position, which may cause them to retain more capital. This in turn may pressure our subsidiaries’ ability to pay dividends to LNC, which may lead us to take steps to preserve or raise additional capital. We believe we have appropriate capital to operate our business in accordance with our strategy. For more information, see “Subsidiaries’ Capital” below.
For factors that could cause actual results to differ materially from those set forth in this section and that could affect our expectations for liquidity and capital, see “Forward-Looking Statements – Cautionary Language” above and “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K.
Consolidated Sources and Uses of Liquidity and Capital
Our primary sources of liquidity and capital are insurance premiums and fees, investment income, maturities and sales of investments, issuance of debt or other types of securities and policyholder deposits. We also have access to alternative sources of liquidity as discussed below. Our primary uses are to pay policy claims and benefits, to fund commissions and other general operating expenses, to purchase investments, to fund policy surrenders and withdrawals, to pay dividends to our common and preferred stockholders, to repurchase our common stock and to repay debt. Our operating activities provided (used) cash of $(400) million and $(2.2) billion for the nine months ended September 30, 2025 and 2024, respectively. Cash flows from operating activities will fluctuate based on the timing of insurance premiums received and benefit payments to policyholders, as well as other business activities including cash payments on certain derivatives used to hedge exposure to product-related risks.
Holding Company Sources and Uses of Liquidity and Capital
The primary sources of liquidity and capital at the holding company level are dividends, return of capital and interest payments from subsidiaries, augmented by holding company short-term investments, bank lines of credit and the ongoing availability of long-term public financing under an effective shelf registration statement, which allows us to issue, in unlimited amounts, securities, including debt securities, preferred stock, common stock, warrants, stock purchase contracts, stock purchase units and depository shares. These sources support the general corporate needs of the holding company, including its common and preferred stock dividends, common stock repurchases, interest and debt service, funding of callable securities, acquisitions and investment in core businesses.
Details underlying the primary sources of the holding company’s liquidity (in millions) were as follows:
| Cash Dividends and Return of Capital from Subsidiaries | For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 |
|---|---|---|---|---|
| The Lincoln National Life Insurance Company | $165 | $125 | $565 | $320 |
| Lincoln Investment Management Company | – | 40 | – | 40 |
| Lincoln National Reinsurance Company (Barbados) Limited | 50 | 50 | 50 | 50 |
| Total cash dividends and return of capital from subsidiaries | $215 | $215 | $615 | $410 |
| Interest from Subsidiaries | ||||
| Interest on inter-company notes | $34 | $40 | $103 | $117 |
The table above focuses on significant and recurring cash flow items and excludes the effects of certain financing activities, including the periodic issuance and retirement of debt, issuance of preferred stock or common stock, cash flows related to our inter-company cash management program and certain investing activities, including capital contributions to subsidiaries. These activities are discussed below. Taxes have been eliminated from the analysis due to a tax sharing agreement among our primary subsidiaries resulting in a modest effect on net cash flows at the holding company. Also excluded from this analysis is the modest amount of investment income on short-term investments of the holding company and employee stock exercise activity related to our stock-based incentive compensation plans. See “Part IV – Item 15(a)(2) Financial Statement Schedules – Schedule II – Condensed Financial Information of Registrant” in our 2024 Form 10-K for the holding company cash flow statement. For information regarding limits on the dividends that our insurance subsidiaries may pay without prior approval, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Restrictions on Subsidiaries’ Dividends” in our 2024 Form 10-K.
During the second quarter of 2024, The Lincoln National Life Insurance Company (“LNL”) made a $929 million extraordinary dividend in the form of investments to LNC for the purpose of the initial capitalization of Lincoln Pinehurst Reinsurance Company (Bermuda) Limited (“LPINE”). See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Significant Operational Matters” in our 2024 Form 10-K for more information about LPINE.
Subsidiaries’ Capital
Our insurance subsidiaries must maintain certain regulatory capital levels. We utilize the RBC ratio as a primary measure of the capital adequacy of our insurance subsidiaries. The RBC ratio is an important factor in the determination of the credit and financial strength ratings of LNC and its subsidiaries, as a reduction in our insurance subsidiaries’ surplus will affect their RBC ratios and dividend-paying capacity. For additional information on RBC ratios, see “Part I – Item 1. Business – Regulatory – Insurance Regulation – Risk-Based Capital” in our 2024 Form 10-K.
Our insurance subsidiaries’ regulatory capital levels are affected by statutory accounting rules, which are subject to change by each applicable insurance regulator. For instance, our term products and UL products containing secondary guarantees subject to the NAIC RBC framework require reserves calculated pursuant to the Valuation of Life Insurance Policies Model Regulation (“XXX”) and Actuarial Guideline XXXVIII (“AG38”), respectively. Our insurance subsidiaries employ strategies to reduce the strain caused by XXX and AG38 by reinsuring the business to reinsurance captives or reinsurance subsidiaries. Our captive reinsurance and reinsurance subsidiaries provide a mechanism for financing a portion of the excess reserve amounts in a more efficient manner and free up capital the insurance subsidiaries can use for any number of purposes, including paying dividends to the holding company. We use long-dated LOCs and debt financing as well as other financing strategies to finance those reserves. Included in the LOCs issued as of September 30, 2025, was $1.7 billion of long-dated LOCs issued to support inter-company reinsurance agreements for term products and UL products containing secondary guarantees. For information on the LOCs, see the credit facilities table in Note 13 in our 2024 Form 10-K. Our captive reinsurance and reinsurance subsidiaries have also issued long-term notes of $3.6 billion to finance a portion of the excess reserves associated with our term and UL products with secondary guarantees as of September 30, 2025; of this amount, $3.0 billion involve exposure to variable interest entities. For information on these long-term notes issued by our captive reinsurance and reinsurance subsidiaries, see Note 4 in our 2024 Form 10-K. We have also used the proceeds from senior note issuances of $875 million to execute long-term structured solutions primarily supporting reinsurance of UL products containing secondary guarantees. LOCs and related capital market solutions lower the capital effect of term products and UL products containing secondary guarantees.
Statutory reserves for variable annuity guaranteed benefit riders and guaranteed benefits on VUL policies, as well as certain components of the NAIC RBC calculation that are impacted by such guaranteed benefits, are sensitive to changes in the equity markets and interest rates, and such statutory reserves and our RBC levels are also affected by the level of account balances relative to the level of any guarantees, product design and reinsurance arrangements. As a result, the relationship between reserve changes and equity market performance is non-linear during any given reporting period. Our insurance subsidiaries cede a portion of the variable annuity guaranteed benefit riders to Lincoln National Reinsurance Company (Barbados) Limited (“LNBAR”) through a modified coinsurance agreement. Our variable annuity hedge program mitigates the risk to LNBAR from guaranteed benefit riders and continues to focus on generating sufficient income to fund future claims with a goal of maximizing distributable earnings and explicitly protecting capital. LNL also uses a partial hedge and a third-party reinsurance agreement to mitigate potential capital volatility from guaranteed benefits on VUL policies. Market conditions greatly influence the ultimate capital required due to its effect on the valuation of reserves and supporting derivatives. For more information, see Note 4 in our 2024 Form 10-K.
Changes in equity markets may also affect the capital position of our insurance subsidiaries. We may decide to reallocate available capital among our insurance subsidiaries, as well as our captive reinsurance or reinsurance subsidiaries, which would result in different RBC ratios for our insurance subsidiaries. In addition, changes in the equity markets can affect the value of our variable annuity and VUL separate accounts. When the market value of our separate account assets increases, the statutory surplus within our insurance subsidiaries also increases, all else equal. Contrarily, when the market value of our separate account assets decreases, the statutory surplus within our insurance subsidiaries also decreases, all else equal, which will affect RBC ratios, and in the case of our separate account assets becoming less than the related product liabilities, we must allocate additional capital to fund the difference.
LNC made $162 million and $967 million in capital contributions in cash to subsidiaries for the three and nine months ended September 30, 2025, respectively, including $800 million to LNL in the second quarter of 2025 using proceeds from the Bain Capital transaction. For more information on the Bain Capital transaction, see “Issuance of Common Stock” below and Note 15 herein.
During the second quarter of 2024, LNC contributed $929 million of investments and $22 million in cash to LPINE, a wholly owned subsidiary of LNC and a licensed Bermuda-based life and annuity reinsurance company, in support of an inter-company reinsurance agreement with LNL. See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Significant Operational Matters” in our 2024 Form 10-K for more information about LPINE.
LNC made capital contributions in cash to other subsidiaries of zero and $5 million for the three and nine months ended September 30, 2024, respectively.
Debt
Although our subsidiaries currently generate adequate cash flow to meet the needs of our normal operations, periodically LNC may issue debt to maintain ratings and increase liquidity, as well as to fund internal growth, acquisitions and the retirement of its debt. Details underlying our debt activities (in millions) for the nine months ended September 30, 2025, were as follows:
| Short-Term Debt | Beginning Balance | Issuance | Maturities, Repayments and Refinancing | Change in Fair Value Hedges | Other Changes (1) | Ending Balance |
|---|---|---|---|---|---|---|
| Current maturities of long-term debt (2) | $300 | $– | $(300) | $– | $– | $– |
| Long-Term Debt | ||||||
| Senior notes (3)(4) | 4,498 | 500 | (299) | 21 | (86) | 4,634 |
| Term loans | 150 | – | – | – | – | 150 |
| Subordinated notes (5)(7) | 995 | – | (194) | – | – | 801 |
| Capital securities (6)(7) | 213 | – | (26) | – | – | 187 |
| Total long-term debt | $5,856 | $500 | $(519) | $21 | $(86) | $5,772 |
(1) Includes the non-cash reclassification of long-term debt to current maturities of long-term debt, premium (discount) associated with debt issuance, accretion (amortization) of discounts and premiums, amortization of debt issuance costs and amortization of adjustments from discontinued hedges, as applicable.
(2) We repaid our 3.35% Senior Notes that matured on March 9, 2025.
(3) For information on the debt issuance, see “Alternative Sources of Liquidity – Facility Agreements for Senior Notes Issuances” below.
(4) In May 2025, we repurchased $34 million of our 3.05% Senior Notes due 2030, $129 million of our 4.35% Senior Notes due 2048 and $136 million of our 4.375% Senior Notes due 2050.
(5) In May 2025, we repurchased $97 million of our Subordinated Notes due 2066 and $97 million of our Subordinated Notes due 2067.
(6) In May 2025, we repurchased $21 million of our Capital Securities due 2066 and $5 million of our Capital Securities due 2067.
(7) We use interest rate swaps to partially hedge the variability in rates.
LNC made interest payments to service debt to third parties of $86 million and $246 million for the three and nine months ended September 30, 2025, respectively, compared to $85 million and $231 million for the three and nine months ended September 30, 2024, respectively.
For additional information about our short-term and long-term debt and our credit facilities, see Note 12 herein and Note 13 in our 2024 Form 10-K.
Preferred Stock
Details underlying preferred stock dividends paid (in millions) were as follows:
| For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Series C preferred stock dividends | $23 | $23 | $46 | $46 |
| Series D preferred stock dividends | 11 | 11 | 34 | 34 |
| Total preferred stock dividends | $34 | $34 | $80 | $80 |
For additional information on preferred stock, see Note 15 herein and Note 18 in our 2024 Form 10-K.
Issuance of Common Stock
On June 5, 2025, we closed our previously announced stock sale transaction pursuant to the Purchase Agreement with Bain Capital Prairie, LLC, a newly formed subsidiary of Bain Capital, under which we agreed to sell shares representing 9.9% of our outstanding common stock on a post-issuance basis to the Buyer. Under the final terms, Lincoln sold approximately 18.8 million shares of its common stock for aggregate consideration of $825 million. The transaction provided us with capital that we expect to deploy toward our strategic priorities, including growing spread-based earnings, advancing our portfolio management efforts and asset sourcing capabilities and optimizing our legacy life portfolio. For additional information on the Bain Capital transaction, see Note 15.
Return of Capital to Common Stockholders
One of our primary goals is to provide a return to our common stockholders through share price accretion, dividends and stock repurchases. In determining dividends, the Board of Directors takes into consideration items such as current and expected earnings, capital needs, rating agency considerations and requirements for financial flexibility. The amount and timing of share repurchases depends on key capital ratios, rating agency expectations, the generation of dividends from our subsidiaries and an evaluation of the costs and benefits associated with alternative uses of capital. We did not repurchase any shares of common stock under our buyback program for the nine months ended September 30, 2025 and 2024. For additional information regarding share repurchases, see “Part II – Item 2(c)” below.
Details underlying return of capital to common stockholders (in millions) were as follows:
| For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Dividends to common stockholders | $85 | $77 | $239 | $229 |
| Total cash returned to common stockholders | $85 | $77 | $239 | $229 |
136
Alternative Sources of Liquidity
Inter-Company Cash Management Program
To meet short-term liquidity needs that arise in the ordinary course of business, we utilize an inter-company cash management program between LNC and participating subsidiaries whereby participating subsidiaries can borrow cash from or lend cash to LNC. Loans under the inter-company cash management program are permitted under applicable insurance laws subject to certain restrictions. For our Indiana-domiciled insurance subsidiary, the borrowing and lending limit is currently 3% of the insurance company’s admitted assets as of its most recent year end. For our New York-domiciled insurance subsidiary, it may borrow from LNC less than 2% of its admitted assets as of its most recent year end but may not lend any amounts to LNC. As of September 30, 2025, LNC had $139 million of outstanding borrowings from the cash management program related primarily to liquidity management.
Facility Agreement for Senior Notes Issuance
On May 13, 2025, LNC exercised in full its issuance right under the 10-year facility agreement, dated as of August 18, 2020 (the “Trust I Facility Agreement”) with Belrose Funding Trust, a Delaware statutory trust (“Trust I”) and on May 15, 2025, LNC issued $500 million aggregate principal amount of its 2.330% Senior Notes due 2030 (the “2.330% Senior Notes”) to Trust I in exchange for the principal and interest strips of U.S. Treasury securities held by Trust I (the “Trust I Eligible Assets”), which had a fair value of $418 million when the 2.330% Senior Notes were issued. The net proceeds from the issuance of the 2.330% Senior Notes and subsequent sale of the Trust I Eligible Assets were used to early extinguish long-term debt during the second quarter of 2025 pursuant to a tender offer. For more information on the early extinguishment of debt, see “Debt” above and Note 12 herein.
On May 20, 2025, LNC entered into a 30-year facility agreement (the “Trust II Facility Agreement”) with Belrose Funding Trust II, a Delaware statutory trust (“Trust II”), in connection with Trust II’s sale of $1.0 billion of its Pre-Capitalized Trust Securities Redeemable May 15, 2055 (the “2055 P-Caps”) in a private placement pursuant to Rule 144A under the Securities Act of 1933, as amended. Trust II invested the proceeds from the sale of the 2055 P-Caps in a portfolio of principal and interest strips of U.S. Treasury securities (the “Trust II Eligible Assets”). The Trust II Facility Agreement provides LNC the right to issue to Trust II, and to require Trust II to purchase from LNC, on one or more occasions, up to an aggregate principal amount outstanding at any one time of $1.0 billion of LNC’s 6.792% Senior Notes due 2055 (the “6.792% senior notes”) in exchange for a corresponding amount of the Trust II Eligible Assets. LNC may direct Trust II to grant all or a portion of the issuance right to one or more assignees (who are LNC’s consolidated subsidiaries or persons to whom LNC or any such consolidated subsidiary has an obligation or liability) (each, an “Issuance Right Assignee”) who may cause a corresponding portion of the 6.792% senior notes to be issued to Trust II and receive the corresponding Trust II Eligible Assets that would otherwise have been delivered to LNC pursuant to the exercise of the issuance right. The 6.792% senior notes will not be issued unless and until the issuance right is exercised. In return, LNC pays Trust II a semi-annual facility fee at a rate of 1.888% per year (applied to the unexercised portion of the issuance right) and reimburses Trust II for its expenses.
For additional information on the facility agreements for senior notes issuances, see Note 12 herein.
Federal Home Loan Bank
Our primary insurance subsidiary, LNL, is a member of the Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”). Membership allows LNL access to the FHLBI’s financial services, including the ability to obtain loans and to issue funding agreements as an alternative source of liquidity that are collateralized by qualifying mortgage-related assets, agency securities or U.S. Treasury securities. Borrowings under this facility are subject to the FHLBI’s discretion and require the availability of qualifying assets at LNL. As of September 30, 2025, LNL had an estimated maximum borrowing capacity of $7.0 billion under the FHLBI facility and maximum available borrowing based on qualifying assets of $4.6 billion. As of September 30, 2025, LNL had outstanding borrowings of $2.0 billion under this facility reported within payables for collateral on investments on the Consolidated Balance Sheets. Lincoln Life & Annuity Company of New York (“LLANY”) is a member of the Federal Home Loan Bank of New York (“FHLBNY”) with an estimated maximum borrowing capacity of $750 million. Borrowings under this facility are subject to the FHLBNY’s discretion and require the availability of qualifying assets at LLANY. As of September 30, 2025, LLANY had no outstanding borrowings under this facility. For additional information, see “Payables for Collateral on Investments” in Note 3.
Repurchase Agreements and Securities Lending Programs
Our insurance and reinsurance subsidiaries had access to $2.6 billion through committed repurchase agreements, of which none was utilized as of September 30, 2025. Our insurance subsidiaries, by virtue of their general account fixed-income investment holdings, can also access liquidity through securities lending programs and uncommitted repurchase agreements. As of September 30, 2025, our insurance subsidiaries had securities pledged under securities lending agreements and uncommitted repurchase agreements with a carrying value of $172 million and $210 million, respectively. For additional information, see “Payables for Collateral on Investments” in Note 3.
Collateral on Derivative Contracts
Our cash flows associated with collateral received from counterparties (when we are in a net collateral payable position) and posted with counterparties (when we are in a net collateral receivable position) change as the market value of the underlying derivative contract changes. The net collateral position depends on changes in interest rates and equity markets related to the amount of the exposures hedged. As of September 30, 2025, we were in a net collateral payable position of $8.7 billion compared to $7.1 billion as of December 31, 2024. In the event of adverse changes in fair value of our derivative instruments, we may need to return, post or pledge collateral to counterparties. If we do not have sufficient high quality securities or cash to provide as collateral to counterparties, we have alternative sources of liquidity. In addition to the liquidity from repurchase agreements and FHLB facilities discussed above, we also have a five-year revolving credit facility discussed in Note 13 in our 2024 Form 10-K. For additional information, see “Credit Risk” in Note 5.
Ratings
Financial Strength Ratings
See “Part I – Item 1. Business – Financial Strength Ratings” in our 2024 Form 10-K for information on our financial strength ratings.
Credit Ratings
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Ratings” in our 2024 Form 10-K for information on our credit ratings.
If our current financial strength ratings or credit ratings were downgraded in the future, terms in our derivative agreements and/or certain repurchase agreements may be triggered, which could negatively affect overall liquidity. For the majority of our derivative counterparties, there is a termination event if the long-term credit ratings of LNC drop below BBB-/Baa3 (S&P/Moody’s) or if the financial strength ratings of LNL drop below BBB-/Baa3 (S&P/Moody’s). For certain repurchase agreements, there is a termination event if the long-term credit ratings of LNC drop below BBB-/Baa3 (S&P/Moody’s) or if the financial strength ratings of LNL drop below BBB+/Baa1 (S&P/Moody’s). In addition, contractual selling agreements with intermediaries could be negatively affected, which could have an adverse effect on overall sales of annuities, life insurance and investment products. See “Part I – Item 1A. Risk Factors – Covenants and Ratings – A downgrade in our financial strength or credit ratings could limit our ability to market products, increase the number or value of policies being surrendered and/or hurt our relationships with creditors” in our 2024 Form 10-K for more information.
Market risk
As filed, 502 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We analyze and manage the risks arising from market exposures of financial instruments, as well as other risks, in an integrated asset-liability management process that considers diversification. We have exposures to several market risks including interest rate risk, equity market risk, credit risk and, to a lesser extent, foreign currency exchange risk. For information on these market risks, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K.
Controls and procedures
As filed, 2,331 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Conclusions Regarding Disclosure Controls and Procedures
We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period required by this report, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act).
Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in timely alerting them to material information relating to us and our consolidated subsidiaries required to be disclosed in our periodic reports under the Exchange Act.
Changes in Internal Control Over Financial Reporting
There was no change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) during the quarter ended September 30, 2025, that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.
A control system, no matter how well designed and operated, can provide only reasonable assurance that the control system’s objectives will be met. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. Projections of any evaluation of control effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
Risk factors
As filed, 717 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the factors set forth in “Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Forward-Looking Statements – Cautionary Language,” you should carefully consider the risks described under “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K. Such risks and uncertainties are not the only ones facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations. If any of these risks actually occur, our business, financial condition and results of operations could be materially affected. In that case, the value of our securities could decline substantially.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $4.55bn | us-gaap:Revenues |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $13.29bn | us-gaap:Revenues |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $79.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | $445.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | $423.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | $2.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | $1.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | $2.15 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | $1.90 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 194,304,105 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 182,851,283 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | −$400.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2025-01-01 to 2025-09-30 | $239.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Total assets | At period end2025-09-30 | $415.27bn | us-gaap:Assets |
| Total liabilities | At period end2025-09-30 | $404.82bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-09-30 | $5.77bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2025-09-30 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-09-30 | $10.45bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000059558-25-000093. Last ingested by Listed: Oct 27, 2026, 14:41 ET. Listed shows no prices and gives no investment advice.